{
  "name" : "_cyber.sci-hub.se_MTAuMjE0Ny9pam4uczEzMjE2Mw==_hemeg2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Nanomaterials for alternative antibacterial therapy",
    "authors" : [ "Hassan A Hemeg" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "© 2017 Hemeg. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you\nhereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).\nInternational Journal of Nanomedicine 2017:12 8211–8225\nsubmit your manuscript | www.dovepress.com Dovepress 8211\nhttp://dx.doi.org/10.2147/IJN.S132163"
    }, {
      "heading" : "Hassan A Hemeg",
      "text" : ""
    }, {
      "heading" : "Department of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, Medina,",
      "text" : "Kingdom of Saudi Arabia\nglobe. They target the severely ill, hospitalized and immunocompromised patients with inca-\npacitated immune system, who are prone to infections. The choice of antimicrobial therapy is\nlargely empirical and not devoid of toxicity, hypersensitivity, teratogenicity and/or mutagenicity.\nThe emergence of multidrug-resistant bacteria further intensifies the clinical predicament as\nit directly impacts public health due to diminished potency of current antibiotics. In addition,\nthere is an escalating concern with respect to biofilm-associated infections that are refractory\nto the presently available antimicrobial armory, leaving almost no therapeutic option. Hence,\nthere is a dire need to develop alternate antibacterial agents. The past decade has witnessed a\nsubstantial upsurge in the global use of nanomedicines as innovative tools for combating the\nhigh rates of antimicrobial resistance. Antibacterial activity of metal and metal oxide nanopar-\nticles (NPs) has been extensively reported. The microbes are eliminated either by microbicidal\neffects of the NPs, such as release of free metal ions culminating in cell membrane damage,\nDNA interactions or free radical generation, or by microbiostatic effects coupled with killing\npotentiated by the host’s immune system. This review encompasses the magnitude of multidrug\nresistance in nosocomial infections, bacterial evasion of the host immune system, mechanisms\nused by bacteria to develop drug resistance and the use of nanomaterials based on metals to\novercome these challenges. The diverse annihilative effects of conventional and biogenic metal\nNPs for antibacterial activity are also discussed. The use of polymer-based nanomaterials and\nnanocomposites, alone or functionalized with ligands, antibodies or antibiotics, as alternative\nantimicrobial agents for treating severe bacterial infections is also discussed. Combinatorial\ntherapy with metallic NPs, as adjunct to the existing antibiotics, may aid to restrain the mounting\nmenace of bacterial resistance and nosocomial threat. Keywords: antibacterial, metallic nanoparticles, microbicidal, nanomedicines, microbial biofilms, antibiotic resistance\nIntroduction Hospital-acquired bacterial infections, mainly caused by the nosocomial pathogens\nsuch as Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli,\nStaphylococcus aureus, Klebsiella pneumoniae and so on, pose the foremost challenge to the well-being of a patient.1 The bacteria counteracts the host’s innate immune defense machinery,2,3 which becomes the prime cause of death in patients confined\nto the intensive care unit (ICU), with weakened immune system, culminating in invasive bloodstream infections. The widespread use of broad-spectrum antibiotics4\nhas led to the appearance of multidrug-resistant (MDR) isolates that further intricate\nthe clinical problem as the bacteria spread epidemically among the patients. With the Correspondence: Hassan A Hemeg Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University, Medina"
    }, {
      "heading" : "30001, Kingdom of Saudi Arabia",
      "text" : "Tel +966 5 0469 6078 Fax +966 4 846 1407 email hasanhemeg@hotmail.com\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8212"
    }, {
      "heading" : "Hemeg",
      "text" : "compromising efficacy of the available chemotherapeutics\ndue to mounting drug resistance and the biofilm recalcitrance\ntowards antibiotics, there is a pressing need to identify alter-\nnate drugs. In this respect, nanomaterials have shown promise owing to their unique physical and chemical attributes.5–7\nTheir large surface area relative to volume enables intimate\ninteractions with microbial membranes, as well as surface\nfunctionalization, which help in developing more effective\nantibacterial agents. Over the last decade, there has been\na remarkable global focus on conventional as well as\nbiogenic metallic nanoparticles (NPs) as innovative tools for\ncombating the high rates of antimicrobial resistance. Chemo-\ntherapeutic drugs when given in combination with metallic\nNPs may result in a cumulative effect due to the antibiotic\nas well as the metal ions released from NPs. Moreover, the\nantibacterial agent may be used at a much lower dose than\nwhen administered alone, hence overcoming the problem\nof resistance and diminishing other undesirable side effects to some extent.6,8 There has also been a paradigm shift in\nmanagement of biofilms and MDR bacteria with polymeric\nnanocomposites and antibiotic-loaded polymeric NPs.\nImproved therapeutic efficacy with concomitant decline in\nside effects of antimicrobial drugs has also been achieved\nby surface modification of metallic NPs with ligands or\nantibodies for targeted delivery.\nThis review summarizes the immune evasion strategies\nand antibiotic resistance mechanisms employed by bacteria to\nsurvive in the host and the probable metallic nanomaterials-\nbased bactericidal effects to fight against nosocomial patho-\ngens. The antibacterial activities of biologically synthesized\nmetallic NPs as well as polymeric nanocomposites and\nsurface-modified NPs are also highlighted. The metal-based\nnanomaterials alone or functionalized with antibiotics when\ntranslated to clinics may show promise as next-generation\nnanotherapeutics against bacterial menace."
    }, {
      "heading" : "Gravity of the problem",
      "text" : "Bacterial infections have emerged as the leading cause of the\nformidable rates of deaths in hospitalized and immunosup-\npressed patients, especially those in ICUs and those undergoing invasive operations, worldwide1,4,9–11 as well as in parts of\nSaudi Arabia where the prevalence has been reported to be 31.7%.12 The hospital-acquired infections manifest in a wide\ngamut of severe clinical ramifications, such as bacteremia,\nseptic shock, ventilator-related pneumonia and massive soft\ntissue necrosis, and rapidly progress to systemic infections that eventually culminate in multiorgan failure and death.13\nThe control measures including implementation of hygiene,\npatient isolation and environmental decontamination have\nproved ineffective in keeping the infection at bay. Improper\nuse of antibiotics has favored an upward trend in the devel-\nopment of resistance to almost all the available drugs, further compounding the clinical problem.9,14 The challenge\nto control these infections is augmented in MDR bacteria such as those producing extended-spectrum β-lactamases and carbapenemases (K. pneumoniae carbapenase) and in\nmethicillin-resistant S. aureus (MRSA). Drug combination\nregimens have also proved ineffective due to formation of\nbiofilms, agglomerates of bacterial colonies that adhere to\na surface and resist traditional means of killing by avoiding contact with the antibiotics.15 The bacteria survive in the\nbiofilms for extended periods of time and are likely to be\ntransmitted within the health care settings. The quandary\nof mechanisms of antibiotic resistance has retrogressed\nthe clinical outcome and inflated the economic burden of\ninfectious diseases, leaving the medical practitioners with few therapeutic options to address the emerging threat.14\nFurthermore, an arsenal of strategies has been employed\nby bacteria to subvert the host immune system, adversely\nimpacting the surrogate markers of clinical course such as\nthe length of hospitalization and hospital-related deaths.\nBacteria’s stratagem: targeting the innate immune defense The bacteria have evolved a diverse array of resistance\nmechanisms to disable key players of the host innate immune\ndefenses for their survival (Figure 1A). They utilize a mul-\ntitude of virulence factors that conjointly render substantial\nimpediment to phagocytes (macrophages and neutrophils) recruitment and activation.3 The bacteria parasitize host\ncells by arresting or reprogramming phagosomal matura-\ntion, by escaping maturing phagosomes or by withstanding\nthe microbicidal properties of the phagolysosome. They\nacquire resistant proteins to withstand low pH environment\nof phagosomes. The bacteria escape neutrophils extracel-\nlular traps (NETs) and elude opsonophagocytosis, and the\ncytocidal effects of host’s antimicrobial peptides (AMPs)\nand reactive oxygen species (ROS). They secrete proteases\nthat cleave NETs, degrade AMPs and express detoxify-\ning enzymes like catalase to neutralize ROS and convert them into less harmful compounds.16 Bacteria may also\nimpair ROS production. Bacteria trigger phagocytic death\nthrough pore-forming cytolysins and escape host complement deposition and activation.2 They release complement-\ndegrading and complement-inactivating enzymes and inhibit\nmembrane attack complex polymerization, thereby impeding\nbacteriolysis. Self-colonization of bacteria to form biofilms further leads to immune subterfuge.6 Bacteria subvert\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8213\nNanomaterials as antibacterial agents\nthe T cell stimulation by dendritic cells (DCs), through\ndownregulation of their antigen-presenting or costimula-\ntory functions. Bacteria may directly infect DC, dampening\nits interleukin (IL)-12 and tumor necrosis factor-alpha (TNF-α) production, thereby crippling the adaptive immune response.17 Immune evasion favors bacterial persistence,\nresulting in increased antibiotic use and selection for MDR\npathogens, thus emphasizing the need for alternate antimicrobial therapies.16"
    }, {
      "heading" : "The emergence of antibiotic resistance",
      "text" : "In the present era, the quintessential antibiotics remain the\nmainstay for management of invasive infections, to anni-\nhilate or restrain the growth of a vast spectrum of bacteria.\nHowever, this perspective advocates ever-expanding threats\naccountable to indiscriminate use of antimicrobials resulting\nin escalated incidence of antibiotic resistance and epidemics of hypervirulent pathogens among vulnerable patients.14\nBacteria have progressively eroded the effectiveness of\nnot only a single antibiotic by developing resistance but\nconcurrently multiple drugs that were previously effective.\nIntracellular bacteria are difficult to treat with regular anti-\nmicrobial therapies, resulting in chronic infections. Medical\ndevices such as catheters, implants and sutures increase the\nrisks of nosocomial infections due to formation of biofilms.\nThe biofilm-related infections are extremely defiant to antimicrobial arsenal and spread rampantly in the community.15\nThe normal gut microbiota that otherwise maintains the\nimmune functions is also targeted by antibiotic spectrum.\nDrug-resistant bacterial infections entail higher doses of\ndrugs, with augmented toxicity, longer hospital stays and\nenhanced mortality. Thus, antimicrobial resistance remains\na substantial global health concern, invigorating the critical\nneed for alternate therapeutic options to combat chronic\nintracellular infections and biofilms so as to shorten the\nhospital stays, and hence mortality.\nDrug resistance subterfuge evolved by bacteria The acquisition of resistance to single and multiple antibiotics\nby bacteria (Figure 1B) has been reported to occur through\nhorizontal gene transfer on plasmids or transposons by\ntransformation, conjugation and transduction or by spontaneously mutating the existing genes.18 The resistance becomes\nrampant due to selective pressure for microbes expressing\nresistance genes against the antimicrobial drug, created by\noveruse of antibiotics, non-patient compliance or use of timedependent drugs with long half-lives or microbiostatic drugs.7 Modes of resistance mechanisms19 that endanger the efficacy\nof antibiotic arsenal are summed up as follows.\nActive antimicrobial drug efflux and reduced uptake Drug efflux pumps preclude the entry of drugs or extrude\nthe antibacterial agent from the microbial cell before it\nFigure 1 Strategies for survival in the host to spark invasive infections. (A) Innate immune mechanisms evaded by bacteria include phagocyte (macrophages, neutrophils) recruitment and activation, opsonization via Fc receptors on macrophages, complement activation and the bactericidal activities of antimicrobial peptides and reactive oxygen species. (B) Drug resistance mechanisms evolved by bacteria comprise hydrolysis by β-lactamases, modification of drug targets or antibiotics, loss or mutation of porins and overexpression of efflux pumps. Abbreviations: AMP, antimicrobial peptide; ROS, reactive oxygen species; AMe, aminoglycoside-modifying enzyme; MDR, multidrug resistant; LPS, lipopolysaccharide.\nβ\nβ\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8214"
    }, {
      "heading" : "Hemeg",
      "text" : "reaches its target site to exert its effect. Overexpression of\ntransmembrane multidrug efflux pumps as well as reduced\nuptake results in sub-toxic levels of drugs within the microbial cells.20 In P. aeruginosa, mutation in regulatory protein\nthat normally dampens the gene encoding efflux proteins\nresults in enhanced outpour. E. coli uses transmembrane\nproton gradient to expel multiple antibiotics through its\nnumerous efflux pumps. The increased drug resistance of\nGram-positive bacteria is also attributed to the outer mem-\nbrane surrounding the periplasmic space that restrains the\nuptake of hydrophobic drugs. The antibiotic uptake or efflux\nmay also be affected by mutations such as the diminished\nexpression or absence of porins in P. aeruginosa, lowering the permeability of the cell wall to carbapenems.21 In case of\nboth Gram-positive and Gram-negative bacteria, one of the\ngenes encoding tetracycline efflux pumps (TetA) is normally\nnot expressed due to TetR repressor protein. However, tetra-\ncycline binds to and inactivates TetR, thereby inducing TetA expression that catalyzes drug efflux.7\nexpression of resistance gene encoding altered substrate The antibacterial agent has diminished affinity for the\nresistance gene-encoded altered antibiotic target sites on\nthe substrate than the wild-type site. This is exemplified\nin case of penicillin-resistant Streptococcus pneumoniae (due to MecA gene conferring resistance to all β-lactams), vancomycin-resistant S. aureus and vancomycin-resistant\nEnterococcus (due to VanA resistance gene), sulfonamide-\nresistant S. pneumoniae, Streptococcus pyogenes, Neisseria spp. and E. coli.7 This mechanism also accounts for con-\nferring resistance against aminoglycosides, macrolides, β-lactams, sulfonamides, linezolid, tetracyclines, rifampin and quinolones.7,22 Resistance genes coding for enzymes\nthat methylate 23S rRNA of the 50S ribosomal subunit and\n16S rRNA of the 30S ribosomal subunit inhibit binding by\nmacrolides (such as erythromycin) and aminoglycosides, respectively.7,23\nCovalent modification of antimicrobial drug, dampening its efficacy Plasmids or transposons and rarely bacterial chromosomes\nharbor resistance genes encoding aminoglycoside-modifying\nenzymes that covalently alter the OH or NH 2 groups on aminoglycosides, thereby undermining their affinity for 30S\nribosomal subunit, and waning their antimicrobial activity. β-Lactamases, having broad-spectrum activity against most of the β-lactam antibiotics, including cephalosporins,\nhave evolved by gene transfer.5,21 Chloramphenicol acetyl-\ntransferases modify chloramphenicol, making it unable to\nbind to 50S ribosomal subunit and inhibit protein synthesis.\nCovalent modification also affords resistance against\ntobramycin, gentamycin, chloramphenicol, kanamycin, macrolides, tetracyclines, quinolones and streptogramins.7,23\nSynthesis of a competitive inhibitor of antibiotic S. aureus and Neisseria meningitidis acquire sulfonamide\nresistance by producing its inhibitor (para-aminobenzoic\nacid) that competes for binding the active site of bacterial dihydropteroate synthetase.7,24 Mutations in this enzyme\nhave also been found in many clinical isolates, downgrading\nsulfonamide-based therapies to second- or third-\nline options.\nBiofilm formation to avoid contact with antibiotics Biofilms are surface-adherent aggregates of bacterial com-\nmunities embedded within an extracellular, self-produced,\npolymeric matrix. Intracellular bacteria in biofilms have\nlimited exposure to antibiotics. Biofilms also act as a bar-\nrier of diffusion by trapping and degrading antibiotics\nand thus render tolerance to even high concentrations of\nantibiotics, a phenomenon called recalcitrance, resulting in\nrecurrent or chronic bacterial infections as with S. aureus and P. aeruginosa.15 Biofilms can also favor gene transfer\nbetween bacteria, thus spreading antibiotic resistance and\ntransforming a previously non-virulent commensal into a virulent pathogen.25"
    }, {
      "heading" : "Nanotechnology-based therapeutic",
      "text" : "interventions to fight nosocomial pathogens Several metals, metal oxides, metal halides and bimetals\nin nanoparticulate form have been documented for antimicrobial activity5,26 as the bacteria are less likely to develop\nresistance to nanomaterials. These comprise NPs containing\nAg, Au, Zn, Cu, Ti, Mg, Ni, Ce, Se, Al, Cd, Y, Pd and super-\nparamagnetic Fe. Zerovalent bismuth-containing NPs have\nshown promise in treating infections due to drug-resistant bacteria in combination with X-rays.27 Among the metal-\ncontaining NPs, Au NPs have moderate antibacterial activity\nunless their surface is modified. Ag NPs are the most effective nano-weapon against bacterial infections.28–30 On the other\nhand, upsurge in resistance to Ag NPs has been reported due to genetic alterations in bacteria.31 The deposition of silver\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8215\nNanomaterials as antibacterial agents\nof Ag NPs in the liver, spleen, lungs and other organs results\nin organ damage and dysfunction, and seriously erodes its\nefficacy. Al 2 O 3 NPs promote horizontal conjugative transfer of MDR genes, increasing antibiotic resistance.32 The high\ntoxicity of CuO NPs causes oxidative lesions, while DNA\ndamage induced by ZnO and TiO 2 NPs limits the efficacy of these NPs. Nonetheless, NPs have emerged as alternative\nantimicrobial approach to combat biofilms and for treating severe bacterial infections.33 The NPs-mediated elimination\nof the microbes may be microbicidal, or the effect may be\nmicrobiostatic, wherein the growth of bacteria is arrested and\nmetabolic activities are ceased and the killing is potentiated\nby the host’s immune cells.\nMode of action of metal-based nanomaterials Metallic NPs use multifaceted contrivance simultaneously\nto combat microbes (Figure 2), depreciating the probability of\ndevelopment of resistance, as it would entail multiple concur-\nrent gene mutations in the same microbe for evolvement of\nthat resistance. The molecular mechanisms by which metal-\nbased NPs annihilate MDR bacteria, resulting in disturbance\nin respiration and inhibition of cellular growth, have been extensively reviewed.28,29,33 Table 1 summarizes the metallic\nNPs that have been reported for antibacterial activity via an\narray of mechanisms enlisted as follows.\nROS generation The toxicity of nanomaterials has been attributed to ROS\nproduction such as hydroxyl radicals, superoxide anions\nand hydrogen peroxide that inhibit DNA replication as\nwell as amino acid synthesis and damage the bacterial cell\nmembranes via lipid peroxidation, compromising membrane\nsemipermeability and repressing oxidative phosphorylation.\nHydroxyl radical (•OH) formation has been observed with Ag NPs28,29,34 and hydrogen peroxide (H 2 O 2 ) with ZnO NPs,35 while TiO 2 NPs36 produce both via photocatalysis. Free Cu++ from Cu-containing NPs37 and Mg halogen (MgX 2 )- containing NPs38 also induce formation of ROS.\nRelease of metal ions and disorganization of bacterial membrane Different microorganisms have varying sensitivities to\nmetal ions. Ag and ZnO NPs have been reported to exert antibacterial activity by release of Ag+ and Zn++ that disrupt the membrane.28,29,35,39 The antibacterial action of Ag NPs is revealed by interaction of Ag+ with sulfhydryl groups\nin enzymes and other cellular constituents, making them\nFigure 2 Probable nanomaterials-based bactericidal effects. Nanomaterials trigger release of heavy metal ions that intercalate between bases, damage cellular proteins, disrupt cell signaling, generate free radicals and prevent biofilm formation. Abbreviation: ROS, reactive oxygen species.\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8216"
    }, {
      "heading" : "Hemeg",
      "text" : "dysfunctional. Ag+ also precludes cell wall synthesis in Gram-positive bacteria. Cu++ interacts with amine and\ncarboxyl groups on the surfaces of microbial cells, such as Bacillus subtilis.40 Au NPs also result in bacterial mem-\nbrane disruption."
    }, {
      "heading" : "Intercalation between DNA bases",
      "text" : "Ag+ released from NPs has also been reported to interact with DNA of microbes,28,29 and inhibit DNA replication\nand cell division. Inhibition of DNA replication and DNA\ndegradation has also been reported with Cu NPs.37,40 Bi NPs\nin combination with X-ray treatment emit electrons, with formation of free radicals that damage bacterial DNA.48\nAdsorption of nanomaterials to bacterial cell The electrostatic interaction between the NPs and the micro-\nbial cells affects its toxicity, with the positively charged NPs\nbeing more toxic as has been observed with TiO 2 and surfacemodified Au NPs.36,41 The NPs adsorption to the surface of\nTable 1 Metallic nanomaterials-based probable bactericidal effects\nNPs Target bacteria Microbicidal effects References\nAg Acinetobacter baumannii, Salmonella typhi, Vibrio cholerae, Bacillus subtilis, Staphylococcus aureus, MDR Escherichia coli, Streptococcus pyogenes, Pseudomonas aeruginosa, coagulase-negative Staphylococcus epidermis, Enterococcus faecalis, Klebsiella pneumoniae, Listeria monocytogenes, Proteus mirabilis, Micrococcus luteus ROS generation, lipid peroxidation, inhibition of cytochromes of eTC, bacterial membrane disintegration, inhibition of cell wall synthesis, increase in membrane permeability, dissipation of proton gradient resulting in lysis, adhesion to cell surface causing lipid and protein damage, ribosome destabilization, intercalation between DNA bases, disruption of biofilms\n28,30,39,52\nAu E. coli, S. aureus, B. subtilis, K. pneumoniae Loss of membrane potential, disruption of respiratory chain, reduced ATPase activity, decline in subunit of ribosome for tRNA binding, bacterial membrane disruption\n41,43\nZnO S. aureus, E. coli, P. aeruginosa, B. subtilis, Stenotrophomonas acidaminiphila\nROS generation, inhibition of biofilm, Zn2+ release, enhanced membrane permeability\n35,46\nMethicillin-resistant Streptococcus agalactiae, MRSA ROS production, disruption of membrane, adsorption to cell surface, lipids and protein damage, inhibition of microbial biofilm formation\n35\nEnterobacter aerogenes, E. coli, Klebsiella oxytoca, S. aureus, S. pyogenes\nCell membrane interaction 53\nCu B. subtilis ROS generation, disorganization of membrane, inhibition of DNA replication\n40\nE. coli Dissipation of cell membrane potential, ROS generation, lipid peroxidation, protein oxidation, DNA degradation\n37\nSe S. aureus, E. coli Biofilm inhibition 49 TiO2 E. coli, P. aeruginosa, S. aureus, Enterococcus\nfaecium ROS generation, adsorption to cell surface, inhibition of biofilm\n36,45\nNiO S. aureus, Streptococcus pneumoniae Increase in bacterial cell wall permeability 44 CdS E. coli Antibiofilm activity 50 YF2 E. coli, S. aureus Antibiofilm properties 48 MgF2 E. coli, S. aureus ROS generation, penetration of cell envelope, lipid\nperoxidation, biofilm inhibition 38\nMgO NP with Cl2 and Br2 E. coli, Bacillus megaterium, B. subtilis Adsorption on cell membrane 54 Bi NP Streptococcus mutans Inhibition of biofilm 27 Bi NPs with X-ray treatment MDR P. aeruginosa Free radical generation that damages bacterial DNA 42 Al2O3 NPs E. coli Cell wall damage, enters cytoplasm 32 Ag/Cu bimetallic NPs E. coli Synergistic effect 55 Cu/Zn bimetal NPs E. coli, S. aureus, MRSA Antioxidant activity 56 Ce-doped TiO2 NPs E. coli Membrane damage, penetration of cell envelope 47 Ag NPs impregnated with TiO2 films E. coli, S. pyogenes, S. aureus, A. baumannii ROS production 36"
    }, {
      "heading" : "Superparamagnetic iron oxide",
      "text" : "NPs coated with Ag or Au E. coli, S. aureus, P. aeruginosa, E. faecalis, S. epidermidis Inhibition of bacterial biofilms 51\nAbbreviations: NPs, nanoparticles; MDR, multidrug resistant; ROS, reactive oxygen species; eTC, electron transport chain; MRSA, methicillin-resistant Staphylococcus aureus.\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8217\nNanomaterials as antibacterial agents\nbacteria results in oxidative stress due to redox reactions,\nleading to toxicity. The adhesion of Ag and ZnO NPs to\nbacterial cell surface also results in damage to membrane lipids and proteins.28,29,35\nAlteration in bacterial membrane permeability Cell surface adherence of Ag and polyvinyl alcohol (PVA)-\ncoated ZnO NPs coupled with ROS generation increases membrane permeability and triggers cell death.28,29,35 The\nmembrane viscosity is also altered, influencing the transport across the membrane. Ag+ released from Ag NPs interacts\nwith negatively charged lipopolysaccharide in the bacterial\nmembrane, permeabilizing it and dissipating the electrochemical proton gradient across the membrane, resulting in lysis.7 Ag+ inhibits cytochromes of the electron transport chain, and\ndisrupt cellular transport systems by causing homeostatic imbalance due to K+ loss from the membrane. Loss of mem-\nbrane potential and disruption of respiratory chain has also been observed with Au,43 Cu37 and NiO NPs.44\nPenetration of the cell envelope and ribosome destabilization The NP surface charge also affects the internalization and\nsubcellular localization and hence toxicity as with CeCl 2 NPs.45 Entering of NPs into the cytoplasm to exert microbi-\ncidal effects via oxidative stress has been observed with Ag nanomaterials28,29 and PVA-coated ZnO NPs.35 MgF 2 NPs cause lipid peroxidation and enter the membrane of micro-\nbial cells, causing a fall in cytoplasmic pH, which raises the membrane potential.38 Al 2 O 3 NPs cause oxidative damage to membrane and enter cytoplasm.32 Ag and Au NPs have\nbeen reported to exert toxicity by penetrating inside the cell\nand denaturing 30S ribosomal subunit, thereby impeding protein translation.29,30,41"
    }, {
      "heading" : "Disruption of bacterial biofilms",
      "text" : "During bacterial biofilm maturation, the extracellular matrix\n(slime) and extracellular carbohydrates known as quorum\nsensing molecules (for cell-to-cell communication) are produced.46 The slow-growing bacterial cells detach, resulting in spread of infection. Ag28,29 and ZnO NPs47 are also docu-\nmented to inhibit the microbial biofilm formation. YF 2 48 and Se NPs49 restrain growth and biofilm formation of E. coli and S. aureus. TiO 2 ,36 CdS,50 MgF 2 38 and Bi NPs27 have also been reported to disrupt bacterial biofilms. Magnetic NPs such\nas superparamagnetic iron oxide NPs coated with Ag or Au exhibit the greatest activity against bacterial biofilms.39,51\nAntibacterial activities of ecofriendly green NPs The potentiality of prokaryotes and plants to reduce inorganic\nmetals has advanced a stimulating, cost-effective strategy towards the NPs synthesis via green nanotechnology.57\nPlant- as well as microbe-mediated metallic NPs synthesis\n(bottom-up or biological method) avoids the generation\nof toxic by-products, and is hence ecofriendly and a green\nalternative to conventional methods (top-down or physical\nmethods and bottom-up or chemical methods) for mining nanomaterials.58 The biologically synthesized metallic NPs\nare biocompatible and potentially safe for human therapeutic\nuse. A plethora of literature highlights the antimicrobial\nactivities of biogenic metallic NPs (Table 2). Rosmarinus\nofficinalis leaf extract-mediated green synthesis of Ag\nNPs has been reported to have remarkable activity against B. subtilis, E. coli, P. aeruginosa and S. aureus,59 while\nbiogenic Ag NPs from Ficus benghalensis and Acalypha\nindica demonstrated antibacterial potential against B. subtilis, E. coli, P. aeruginosa and Vibrio cholerae.60 Ag NPs synthesized using leaves extract of Skimmia laureola,61 root extract of Delphinium denudatum,62 Styrax benzoin extract63 and Rosa chinensis flower extract64 showed potent antibacterial\neffects against a spectrum of Gram-positive and Gram-\nnegative human pathogenic bacteria. Ag NPs synthesized\nusing Caesalpinia sappan extract served as a potential novel nanoantibiotic against MRSA.65 Biologically synthesized Ag\nNPs using Coffea arabica seed extract have been found to\nexhibit significant antibacterial activity against E. coli and\nS. aureus, that was almost equivalent to that elicited with the standard drug ampicillin.66 Inhibitory activity of green synthesized ZnO NPs from Solanum nigrum,67 CeO 2 NPs from Olea europaea leaf extract,68 and Fe 3 O 4 -Ag core shell magnetic NPs obtained using Vitis vinifera stem extract69\nagainst both Gram-positive and Gram-negative pathogens has\nalso been reported. The antibacterial activities of biologically\nsynthesized NPs are due to the metal ions released from\nthe NPs, coupled with the bio-organic compounds used\nin the green synthesis that may interact with the microbial\nmembrane as well as preclude the need for reducing and stabilizing agent.70 However, the biosynthetic NPs have not\nbeen found to surpass the non-biosynthetic NPs in antibacte-\nrial effects or vice versa.\nImmunomodulatory effects of nanomaterials based on metals Metal-based NPs are known to trigger innate as well as adaptive immune responses.86 The immunostimulatory\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8218"
    }, {
      "heading" : "Hemeg",
      "text" : "potential of Ag, CeO 2 and surface-modified Au NPs has been reported.87 Immunostimulatory NPs may serve as double-\nedged swords by acting on bacteria as biocidal nanoweap-\nons, as well as undermining the bacterial resistance to host immunity. ZnO NPs increased interferon gamma, TNF-α and IL-12 expression in primary human immune cells,88 while in another study, IL-6, IL-1β, IL-8 and TNF-α were induced by ZnO NPs from peripheral blood mononuclear cells.53 TiO\n2 89\nand SiO 2 NPs90 activated inflammasomes and induced IL-1β release, which affected fibroblast proliferation. Ag NPs also induced inflammasome formation and triggered IL-1β release and subsequent caspase-1 activation.91 Size-dependent immu-\nnomodulatory effect of Au NPs has been reported that may\ninhibit IL-12p70 production by DCs and Th2 polarization, or promote Th17 potentiation.92 CeO 2 NPs stimulated IL-10 production from DCs and triggered a strong Th2-biased\ncytokine profile. On the contrary, TiO 2 NPs induced DCs to\nrelease IL-12 and polarize T cells to a Th1-bias.93 TiO 2 NPs and nanoplatinum triggered proinflammatory cytokine\nproduction, DC maturation and näive T cell activation and proliferation.94,95 A benign ε-polylysine/Ag nanocomposite has been reported to modulate the relative levels of CD3+ T cells and CD68+ macrophages and promote infected wound healing.96\nSynergistic antibacterial effects of nanomaterials with antibiotics or alternate antimicrobial compounds While most metal-based NPs are microbicidal to an array\nof bacteria, genetic alterations in bacteria may result in rapid evolution of resistance to Ag NPs,31 whereas Al 2 O 3 NPs trigger increased expression of conjugation-promoting\ngenes, thus promoting horizontal transfer of antibiotic resis-\ntance genes. NPs have been tailored to subdue resistance\nTable 2 Antibacterial activities of green NPs\nGreen synthesized NPs Target bacteria Antibacterial effects References\nAg NPs from Phyllanthus amarus extract MDR Pseudomonas aeruginosa Membrane damage, release of free ions, inactivation of enzymes by interaction with thiol groups\n71\nAg NPs from Helicteres isora fruit extract extensively drug-resistant (XDR) P. aeruginosa isolates\nLipid peroxidation, leakage of reducing sugars and proteins, respiratory chain dehydrogenases inactivation, turbulence of membrane permeability\n72\nAg NPs from Artemisia cappilaris extract Methicillin-resistant Staphylococcus aureus Membrane damage, release of free ions 73 Ag NPs from aloe vera extract Staphylococcus epidermidis, P. aeruginosa Release of free ions, increase in membrane\npermeability, ROS production, DNA damage 70\nAg NPs from Acalypha indica leaf extracts Escherichia coli, Vibrio cholerae Alteration in membrane permeability and respiratory chain\n74\nAg NPs from Rhizopus oryzae E. coli, P. aeruginosa ROS production, membrane damage, alteration in membrane permeability\n75\nAg NPs from extracts of Cocus nucifera influorescence\nVibrio alginolyticus, Klebsiella pneumoniae, P. aeruginosa, Bacillus subtilis, Plesiomonas shigelloides Interference with the molecular build-up of bacterial cell wall 76\nAg, Zn NPs extracted from Caltropis procera fruits or leaves\nV. cholerae, E. coli Inhibition of adenyl cyclase, restraining biofilm formation\n77\nAu NPs from Citrullus lanatus rind Bacillus cereus, E. coli, Listeria monocytogenes, S. aureus, Salmonella typhi Antioxidant activities 78 Ag, Au, Ag–Au bimetallic NPs extracted from Plumbago zeylanica E. coli, Acinetobacter baumannii, S. aureus Biofilm inhibition 79"
    }, {
      "heading" : "Ag, Au and Ag/Au bimetallic NPs using",
      "text" : "Gloriosa superba leaf extract S. aureus, Streptococcus pneumoniae, K. pneumoniae, E. coli Antibiofilm activities 80 Ni NPs from Ocimum sanctum leaf extract E. coli, K. pneumoniae, S. typhi, B. subtilis, S. epidermidis\nROS production, release of free ions, membrane damage, inhibition of electron transport\n81\nAl2O3 NPs from leaf extract of lemongrass MDR P. aeruginosa Intracellular oxidative stress contributing to loss of cell membrane integrity 82 Pd NPs using agroforest waste Moringa oleifera Enterococcus faecalis, B. cereus, S. aureus, E. coli Antioxidant activity 83 Se NPs from Bacillus licheniformis B. cereus, E. faecalis, S. aureus, E. coli, S. typhi, Salmonella enteritidis, S. aureus Antibiofilm activity 84,85\nAbbreviations: NPs, nanoparticles; MDR, multidrug resistant; ROS, reactive oxygen species.\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8219\nNanomaterials as antibacterial agents\nby packaging multifarious antimicrobial agents, resulting\nin development of resistance, which is a subtle possibility\nsince it would require multiple simultaneous gene mutations in the same bacteria.97,98\nThe functionalization of NPs using antibiotics (Table 3)\nis not only a promising nanoplatform to combat bacterial\nresistance but may also reduce the dose and hence toxicity\nof the drugs. NPs target or deliver antimicrobial agents to\nthe infected site, thereby overcoming resistance as well as\nmitigating their hazardous impact on normal cells. Syner-\ngistic antibacterial efficiency of Ag NPs and antibiotics has\nbeen observed against S. aureus, E. coli and P. aeruginosa at extremely low concentrations.99 The efficacy of ampicillin\ncoupled with Ag NPs was identical in Gram-positive and\nGram-negative bacteria, unlike the difficulty in inhibition of Gram-positive bacteria with Ag NPs alone.39 Green synthe-\nsized NPs may also be used as an antibiotic adjuvant for the\ntreatment of various bacterial infections (Table 3). Ag NPs\nboost the antimicrobial effects of several antibiotics, includ-\ning penicillin G, amoxicillin, vancomycin, clindamycin and erythromycin against S. aureus, E. coli and MDR bacteria.100\nThe antibiotic-functionalized NPs may promote reversal of\nantimicrobial resistance.\nCombinatorial effect of Ag NPs with natural alternative compounds such as cinnamaldehyde117 and eugenol118 has\nalso been reported. Se NPs conjugated with quercetin and\nTable 3 Drug–nanomaterial synergy for antibacterial therapy"
    }, {
      "heading" : "Nanomaterials Antibiotics Affected bacteria References",
      "text" : "Ag NPs Chloramphenicol Salmonella typhi 101 Enterococcus faecium, Pseudomonas aeruginosa 102\nPolymyxin B, rifampicin Acinetobacter baumannii 103 vancomycin Enterobacter aerogenes 39 Ampicillin MRSA, P. aeruginosa, E. aerogenes, Escherichia coli 104\nE. coli, E. faecium, Streptococcus mutans, Staphylococcus aureus, P. aeruginosa\n102\nCiprofloxacin vRe 105 vancomycin vRe, E. coli vancomycin MRSA 106 Clotrimazole MRSA, S. aureus 107\nAg NPs plus blue light Amoxicillin, azithromycin, clarithromycin, linezolid\nMRSA 108\nγ-Cyclodextrin-capped Ag NPs Chloramphenicol P. aeruginosa, Enterococcus faecalis, Klebsiella pneumoniae, S. aureus\n109\nAu NPs Ampicillin MRSA, P. aeruginosa, E. aerogenes, E. coli 104 vancomycin vRe, E. coli 110 vancomycin MRSA 106 Kanamycin Streptococcus bovis, Staphylococcus epidermidis,\nE. aerogenes, P. aeruginosa, Yersinia pestis 111\nStreptomycin, gentamycin, neomycin S. aureus, Micrococcus luteus, E. coli, P. aeruginosa 54 ZnO NPs Ciprofloxacin, ceftazidime MDR A. baumannii 112\nCiprofloxacin, erythromycin, methicillin, vancomycin\nE. faecalis, E. faecium 105"
    }, {
      "heading" : "Ag NPs from leaf extract of",
      "text" : "Typha angustifolia\nGentamicin, cefotaxime, meropenem E. coli, K. pneumoniae 113\nAg NPs from Acinetobacter calcoaceticus vancomycin E. aerogenes 114 β-Lactam antibiotics MDR A. baumannii, vancomycin-resistant S. mutans Ag NPs from E. coli Bacitracin E. coli, Salmonella paratyphi B 58 Ampicillin Corynebacterium diphtheriae Kanamycin K. pneumoniae Gentamycin P. aeruginosa Bacitracin, gentamycin, erythromycin, ciprofloxacin S. aureus"
    }, {
      "heading" : "Citrate-capped Ag NPs from",
      "text" : "Allium sativum Cephalothin, cefazolin, chloramphenicol M. luteus, Bacillus subtilis, P. aeruginosa, E. coli 115 Au NPs from Adiantum philippense extract Amoxicillin MRSA 116 Au NPs from Citrullus lanatus rind Kanamycin, rifampicin Bacillus cereus, E. coli, Listeria monocytogenes,\nS. aureus, S. typhi 78\nAbbreviations: NPs, nanoparticles; MRSA, methicillin-resistant Staphylococcus aureus; vRe, vancomycin-resistant Enterococcus; MDR, multidrug resistant.\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8220"
    }, {
      "heading" : "Hemeg",
      "text" : "acetylcholine had synergistic effect against MRSA, causing irreversible membrane damage.119 Resveratrol nanocarriers\nwith Au NPs and Ag NPs had potent activity against Grampositive and Gram-negative bacteria.120 The combination of\nbiologically synthesized Ag NPs (produced by Fusarium\noxysporum) and oregano (Origanum vulgare) essential oil\nshowed bactericidal effects against non-methicillin-resistant S. aureus (non-MRSA) and β-lactamase- and carbapenemaseproducing E. coli and A. baumannii strains.121 Nigella sativa\nessential oil-synthesized Au NPs effectively inhibited the biofilm formation of S. aureus and Vibrio harveyi.122\nPolymeric nanocomposites and nanomaterials conjugated with antibodies and other ligands and drug–NP complex for targeted delivery Antimicrobial NPs can be easily trapped within polymer\nfilms to form lipid–polymer hybrid NPs or nanocomposites.\nEnhanced biocompatibility and stability coupled with con-\ntrolled release make these superior alternatives to metallic\nNPs. Synergistic antibacterial effects of some polymers and\nmetal nanomaterials have been identified. The biocidal activi-\nties of Ag and Cu NPs embedded in polymer matrices have\nbeen reported to be enhanced due to release of metal ions while dampening their toxicities.55,123 Ag nanocomposites have been reported to be biocidal against MRSA.124 A benign ε-polylysine/Ag nanocomposite demonstrated antibacterial effects against P. aeruginosa and S. aureus that was mediated\nby surface adherence, irreversible disruption of the membrane\nwith subsequent penetration and inhibition of protein activity, ultimately leading to bacterial apoptosis.96 Low-density\npolyethylene-containing ZnO nanocomposites have been\nfound to be effective against B. subtilis and Enterobacter aerogenes.125 Ag/Fe 3 O 4 nanocomposites demonstrated high antibacterial activity against E. coli126 and graphene-oxide Ag nanocomposites against MRSA.127\nTargeted NP delivery to the infection site could also be\nachieved by surface modification with ligands or antibodies,\nwhich may further improve therapeutic efficacy and reduce\nthe side effects of antimicrobial drugs. The effectiveness of\nAg NPs is also augmented with compounds such as polyeth-\nyleneimines, chitosan and glucosamine that serve as ligands and reinforce their uptake into bacterial cells.128 Chitosan has\ninherent antimicrobial properties due its polycationic char-\nacter. Low-molecular weight chitosan-coated Ag NPs have\nbeen reported to surpass polyvinylpyrrolidone-coated Ag NPs\nand Ag NPs without surface stabilizer (uncoated Ag NPs) in\nefficacy against MRSA with enhanced biocompatibility and reduced body absorption characteristics.129 Chitosan/TiO 2 / Ag nanocomposites exhibited effective antibacterial activ-\nity via ROS generation, lactate dehydrogenase release and inhibited bacterial adhesion.130 Chitosan/Ag nanocomposites were effective against Salmonella sp.,131 whereas the activ-\nity of chitosan-TiO 2 :Cu nanocomposite against E. coli and S. aureus was enhanced in the presence of light.132 Chitosan/ calcium silicate nanocomposites doped with Ag+ exhibited antibacterial activity against S. aureus and P. aeruginosa.133\nAg NPs capped with lipoic acid were effective against\nStaphylococcus epidermidis and Streptococcus mutans biofilm.134 Ag-decorated poly (DL-lactide-co-glycolide) NPs exhibited high efficacy against S. epidermidis biofilms.135\nBiodegradable lignin-core NPs coated with cationic polyelectrolytes and infused with Ag+ exhibited broad-spectrum\nbiocidal activity against Gram-positive as well as Gramnegative bacteria at lower concentrations of Ag+ than the\nconventional Ag NPs and hence suggested as greener alternatives to Ag NPs.136 Antibacterial (P. aeruginosa)\nactivity of iron oxide NPs was also enhanced upon chitosan coating.137 Superior antibacterial activity of UV-irradiated\nglucosamine-functionalized Au NPs on graphene oxide\nagainst E. coli and Enterococcus faecalis has been reported that was better than kanamycin.138 Gallic acid-capped Au NPs\nhave been found to be effective against both Gram-positive and Gram-negative bacteria.139 Synthetic peptides (contain-\ning arginine, tryptophan and cysteine termini)-immobilized\nAu NPs exhibited targeting capacity and activity against\nStaphylococci, Enterococci and antibiotic-resistant bacterial strains.140 Microbial (Ochrobactrum rhizosphaerae)\nglycolipoprotein-capped Ag NPs exhibited antibacterial activity against V. cholerae comparable to ciprofloxacin.141\nBesides the targeting ligands, NPs conjugated with anti-\nbodies against surface antigen of the target microbe such\nas anti-protein A antibodies have been shown to have high\nselectivity for killing S. aureus. Conjugating Bi NPs to\nantibodies against the target has been found to be effective\nagainst MDR P. aeruginosa when irradiated with low-dose X-rays.54 Similarly, the IgG in IgG-Fe 3 O 4 @TiO 2 magnetic NPs has been shown to target S. pyogenes.54\nDrug–NP complex represents another type of polymeric\nNPs that are highly attractive as drug delivery vehicles due to\ntheir stability, ease of functionalization and sustained release.\nThese may be made multifunctional by incorporating different\npolymers. Chitosan-functionalized Au NPs adsorbed on\nvancomycin-encapsulated liposomes released the antibiotic\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8221\nNanomaterials as antibacterial agents\nin the presence of anti-toxin antibody secreted by S. aureus, inhibiting its growth.142 Lipids like phosphatidylinositol and\nstearylamine presented specific affinity with biofilms, thereby\nincreasing the biofilm adhesion of liposomes. Anti-biofilm\nactivities of phosphatidylcholine-decorated Au NPs loaded with\ngentamycin have been reported against P. aeruginosa, S. aureus as well as intracellular Listeria monocytogenes and E. coli.143\nNP-based drug delivery could subjugate systemic toxic effects\nof antibiotics, decrease uptake and increase efflux of drugs,\nbiofilm formation and intracellular bacterial infection."
    }, {
      "heading" : "Conclusion and perspectives",
      "text" : "Bacteria are increasingly dodging extermination as they have\nevolved innate immune resistance strategies. Antibiotics\nremain the mainstay to fight bacterial infections, but epi-\nsodes of resistant infections are alarmingly on the rise. The\nindiscriminate use of antimicrobial agents in the community,\nhospital and agriculture is undeniably responsible for fuel-\nling this crisis. This also causes selective pressure, allowing\nonly the fittest genotype to thrive, resulting in emergence of\nMDR bacterial strains, and emphasizing the need for surrogate\ntherapeutic options. The emergence of resistant and more\nvirulent strains of bacteria has outpaced the development of\nnew antibiotics over the last few decades. NPs are now being\nconsidered as a viable alternative to antibiotics due to their\nbiocidal and immunopotentiating properties. The polymer-\nbased nanomaterials and metal NPs may also be exploited\nas antimicrobial coatings on surface of medical devices for\nvarious biomedical applications. Metallic NPs when used with\nthe existing antibiotics for bacterial infections lower the anti-\nbiotics dosage to be administered, thereby minimizing toxicity\nas well as reducing the probability of development of resis-\ntance. There has been a paradigm shift towards cost-effective\nand ecofriendly green synthesis of antibacterial NPs. This\napproach holds promise alone or synergistically with antibiot-\nics targeting various bacterial infections, paving way for future\ntherapeutics in nanomedicine. This combinatorial approach\nmay serve as adjunct to the existing therapies and may help\nto restrain the escalating nosocomial threats. However, their\ntranslation to clinics would entail an in-depth understanding\nof the pharmacokinetics and biodistribution of NPs."
    }, {
      "heading" : "Disclosure",
      "text" : "The author reports no conflicts of interest in this work."
    }, {
      "heading" : "Hemeg",
      "text" : "23. Cox G, Stogios PJ, Savchenko A, Wright GD. Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2″)-la. MBio. 2015;6(1). 24. Yun MK, Wu Y, Li Z, et al. Catalysis and sulfa drug resistance in dihydropteroate synthase: crystal structures reveal the catalytic mechanism of DHPS and the structural basis of sulfa drug action and resistance. Science. 2012;335(6072):1110–1114. 25. Zhu X, Radovic-Moreno AF, Wu J, Langer R, Shi J. Nanomedicine in the management of microbial infection – overview and perspectives. Nano Today. 2014;9(4):478–498. 26. Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl. 2014;44:278–284. 27. Hernandez-Delgadillo R, Velasco-Arias D, Diaz D, et al. Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm. Int J Nanomedicine. 2012;7:2109–2113. 28. Dakal TC, Kumar A, Majumdar RS, Yadav V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol. 2016; 7:1831. 29. Durán N, Durán M, de Jesus MB, Seabra AB, Fávaro WJ, Nakazato G. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine. 2016;12(3):789–799. 30. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol. 2012;112(5):841–852. 31. Graves JL Jr, Tajkarimi M, Cunningham Q, et al. Rapid evolution of silver nanoparticle resistance in Escherichia coli. Front Genet. 2015;6:42. 32. Ansari MA, Khan HM, Khan AA, Cameotra SS, Saquib Q, Musarrat J. Interaction of Al\n(2) O (3) nanoparticles with Escherichia coli and their cell\nenvelope biomolecules. J Appl Microbiol. 2014;116(4):772–783. 33. Oktar FN, Yetmez M, Ficai D, Ficai A, Dumitru F, Pica A. Molecular\nmechanism and targets of the antimicrobial activity of metal nanoparticles. Curr Top Med Chem. 2015;15(16):1583–1588. 34. Łysakowska ME, Ciebiada-Adamiec A, Klimek L, Sienkiewicz M. The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp. Burns. 2015;41(2):364–371. 35. Sirelkhatim A, Mahmud S, Seeni A, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett. 2015;7(3):219–242. 36. Wong MS, Chen CW, Hsieh CC, Hung SC, Sun DS, Chang HH. Antibacterial property of Ag nanoparticle-impregnated N-doped titania films under visible light. Sci Rep. 2015;5:11978. 37. Chatterjee AK, Chakraborty R, Basu T. Mechanism of antibacterial activity of copper nanoparticles. Nanotechnology. 2014;25(13):135101. 38. Lellouche J, Friedman A, Lahmi R, Gedanken A, Banin E. Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomedicine. 2012;7:1175–1188. 39. Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20(5):8856–8874. 40. Yoon KY, Hoon Byeon J, Park JH, Hwang J. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ. 2007;373(2–3):572–575. 41. Shamaila S, Zafar N, Riaz S, Sharif R, Nazir J, Naseem S. Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen. Nanomaterials (Basel). 2016;6(4). 42. Luo Y, Hossain M, Wang C, et al. Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. Nanoscale. 2013;5(2):687–694. 43. Huo S, Jiang Y, Gupta A, et al. Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure. ACS Nano. 2016;10(9):8732–8737. 44. Khashan KS, Sulaiman GM, Abdul Ameer FA, Napolitano G. Synthesis, characterization and antibacterial activity of colloidal NiO nanoparticles. Pak J Pharm Sci. 2016;29(2):541–546. 45. Ali Z, Raj B, Vishwas M, Athhar MA. Synthesis, characterization and antimicrobial activity of Ce doped TiO\n2 nanoparticles. Int J Curr\nMicrobiol Appl Sci. 2016;5(4):705–712.\n46. Neethirajan S, Clond MA, Vogt A. Medical biofilms–nanotechnology approaches. J Biomed Nanotechnol. 2014;10(10):2806–2827. 47. Lee JH, Kim YG, Cho MH, Lee J. ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production. Microbiol Res. 2014;169(12):888–896. 48. Lellouche J, Friedman A, Gedanken A, Banin E. Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles. Int J Nanomedicine. 2012;7:5611–5624. 49. Guisbiers G, Wang Q, Khachatryan E, et al. Inhibition of E. coli and S. aureus with selenium nanoparticles synthesized by pulsed laser ablation in deionized water. Int J Nanomedicine. 2016;11:3731–3736. 50. Dhanabalan K, Gurunathan K. Microemulsion mediated synthesis and characterization of CdS nanoparticles and its anti-biofilm efficacy against Escherichia coli ATCC 25922. J Nanosci Nanotechnol. 2015; 15(6):4200–4204. 51. Liakos I, Grumezescu AM, Holban AM. Magnetite nanostructures as novel strategies for anti-infectious therapy. Molecules. 2014;19(8): 12710–12726. 52. Nour El Din S, El-Tayeb TA, Abou-Aisha K, El-Azizi M. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa. Int J Nanomedicine. 2016;11:1749–1758. 53. Esparza-González SC, Sánchez-Valdés S, Ramírez-Barrón SN, et al. Effects of different surface modifying agents on the cytotoxic and antimicrobial properties of ZnO nanoparticles. Toxicol In Vitro. 2016;37: 134–141. 54. Grumezescu A, editor. Nanobiomaterials in Antimicrobial Therapy: Applications of Nanobiomaterials. 1st ed. Elsevier, USA; 2016. 55. Perdikaki A, Galeou A, Pilatos G, et al. Ag and Cu monometallic and Ag/Cu bimetallic nanoparticle-graphene composites with enhanced antibacterial performance. ACS Appl Mater Interfaces. Epub 2016 Oct 11. 56. Ashfaq M, Verma N, Khan S. Copper/zinc bimetal nanoparticlesdispersed carbon nanofibers: a novel potential antibiotic material. Mater Sci Eng C Mater Biol Appl. 2016;59:938–947. 57. Park Y. New paradigm shift for the green synthesis of antibacterial silver nanoparticles utilizing plant extracts. Toxicol Res. 2014;30(3): 169–178. 58. Gandhi H, Khan S. Biological synthesis of silver nanoparticles and its antibacterial activity. J Nanomed Nanotechnol. 2016;7:366. 59. Ghaedi M, Yousefinejad M, Safarpoor M, Khafri HZ, Purkait MK. Rosmarinus officinalis leaf extract mediated green synthesis of silver nanoparticles and investigation of its antimicrobial properties. J Ind Eng Chem. 2015;25:167–172. 60. Nayak D, Ashe S, Rauta PR, Kumari M, Nayak B. Bark extract mediated green synthesis of silver nanoparticles: evaluation of antimicrobial activity and antiproliferative response against osteosarcoma. Mater Sci Eng C Mater Biol Appl. 2016;58:44–52. 61. Ahmed MJ, Murtaza G, Mehmood A, Bhatti TM. Green synthesis of silver nanoparticles using leaves extract of Skimmia laureola: characterization and antibacterial activity. Mater Lett. 2015;153:10–13. 62. Suresh G, Gunasekar PH, Kokila D, et al. Green synthesis of silver nanoparticles using Delphinium denudatum root extract exhibits antibacterial and mosquito larvicidal activities. Spectrochim Acta A Mol Biomol Spectrosc. 2014;127:61–66. 63. Du J, Singh H, Yi TH. Antibacterial, anti-biofilm and anticancer potentials of green synthesized silver nanoparticles using benzoin gum (Styrax benzoin) extract. Bioprocess Biosyst Eng. 2016;39(12):1923–1931. 64. Meng Y, Sun Y. Development of biogenic silver nanoparticle using Rosa chinensis flower extract and its antibacterial property. J Nanosci Nanotechnol. 2016;16(4):3969–3972. 65. Jun SH, Cha SH, Kim JH, Yoon M, Cho S, Park Y. Silver nanoparticles synthesized using Caesalpinia sappan extract as potential novel nanoantibiotics against methicillin-resistant Staphylococcus aureus. J Nanosci Nanotechnol. 2015;15(8):5543–5552. 66. Dhand V, Soumya L, Bharadwaj S, Chakra S, Bhatt D, Sreedhar B. Green synthesis of silver nanoparticles using Coffea arabica seed extract and its antibacterial activity. Mater Sci Eng C Mater Biol Appl. 2016;58: 36–43. In te rn at io na l J ou rn al o f N an om ed ic in e do w nl oa de d fr om h ttp s: //w w w .d ov ep re ss .c om / b y 17 8. 15 9. 10 0. 16 8 on 2 7- Ju l-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8223\nNanomaterials as antibacterial agents\n67. Ramesh M, Anbuvannan M, Viruthagiri G. Green synthesis of ZnO nanoparticles using Solanum nigrum leaf extract and their antibacterial activity. Spectrochim Acta A Mol Biomol Spectrosc. 2015;136(Pt B): 864–870. 68. Maqbool Q, Nazar M, Naz S, et al. Antimicrobial potential of green synthesized CeO\n2 nanoparticles from Olea europaea leaf extract. Int J\nNanomedicine. 2016;11:5015–5025. 69. Venkateswarlu S, Kumar BN, Prathima B, Anitha K, Jyothi NVV.\nA novel green synthesis of Fe 3 O 4 -Ag core shell recyclable nanoparticles using Vitis vinifera stem extract and its enhanced antibacterial performance. Physica B Condens Matter. 2015;457:30–35. 70. Tippayawat P, Phromviyo N, Boueroy P, Chompoosor A. Green synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activity. PeerJ. 2016;4:e2589. 71. Singh K, Panghal M, Kadyan S, Chaudhary U, Yadav JP. Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Nanobiotechnology. 2014;12:40. 72. Mapara N, Sharma M, Shriram V, Bharadwaj R, Mohite KC, Kumar V. Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa. Appl Microbiol Biotechnol. 2015;99(24): 10655–10667. 73. Jang H, Lim SH, Choi JS, Park Y. Antibacterial properties of cetyltrimethylammonium bromide-stabilized green silver nanoparticles against methicillin-resistant Staphylococcus aureus. Arch Pharm Res. 2015;38(10):1906–1912. 74. Krishnaraj C, Jagan EG, Rajasekar S, Selvakumar P, Kalaichelvan PT, Mohan N. Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against water borne pathogens. Colloids Surf B Biointerfaces. 2010;76(1):50–56. 75. Ramalingam B, Parandhaman T, Das SK. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of Gram-Negative Bacteria viz. Escherichia coli and Pseudomonas aeruginosa. ACS Appl Mater Interfaces. 2016; 8(7):4963–4976. 76. Mariselvam R, Ranjitsingh AJ, Usha Raja Nanthini A, Kalirajan K, Padmalatha C, Mosae Selvakumar P. Green synthesis of silver nanoparticles from the extract of the inflorescence of Cocos nucifera (Family: Arecaceae) for enhanced antibacterial activity. Spectrochim Acta A Mol Biomol Spectrosc. 2014;129:537–541. 77. Salem W, Leitner DR, Zingl FG, et al. Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli. Int J Med Microbiol. 2015;305(1):85–95. 78. Patra JK, Baek KH. Novel green synthesis of gold nanoparticles using Citrullus lanatus rind and investigation of proteasome inhibitory activity, antibacterial, and antioxidant potential. Int J Nanomedicine. 2015;10:7253–7264. 79. Salunke GR, Ghosh S, Santosh Kumar RJ, et al. Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control. Int J Nanomedicine. 2014;9:2635–2653. 80. Gopinath K, Kumaraguru S, Bhakyaraj K, et al. Green synthesis of silver, gold and silver/gold bimetallic nanoparticles using the Gloriosa superba leaf extract and their antibacterial and antibiofilm activities. Microb Pathog. 2016;101:1–11. 81. Pandian CJ, Palanivel R, Dhanasekaran S. Screening antimicrobial activity of nickel nanoparticles synthesized using Ocimum sanctum leaf extract. J Nanoparticles. 2016;2016:4694367. 82. Ansari MA, Khan HM, Alzohairy MA, et al. Green synthesis of Al 2 O 3\nnanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa. World J Microbiol Biotechnol. 2015;31(1):153–164. 83. Anand K, Tiloke C, Phulukdaree A, et al. Biosynthesis of palladium nanoparticles by using Moringa oleifera flower extract and their catalytic and biological properties. J Photochem Photobiol B. 2016;165: 87–95.\n84. Khiralla GM, El-Deeb BA. Antimicrobial and antibiofilm effects of selenium nanoparticles on some foodborne pathogens. LWT – Food Sci Technol. 2015;63(2):1001–1007. 85. Sonkusre P, Singh Cameotra S. Biogenic selenium nanoparticles inhibit Staphylococcus aureus adherence on different surfaces. Colloids Surf B Biointerfaces. 2015;136:1051–1057. 86. Luo YH, Chang LW, Lin P. Metal-based nanoparticles and the immune system: activation, inflammation, and potential applications. Biomed Res Int. 2015;2015:143720. 87. Jiao Q, Li L, Mu Q, Zhang Q. Immunomodulation of nanoparticles in nanomedicine applications. Biomed Res Int. 2014;2014: 426028. 88. Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett. 2009;4(12): 1409–1420. 89. Yazdi AS, Guarda G, Riteau N, et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci U S A. 2010;107(45):19449–19454. 90. Peeters PM, Perkins TN, Wouters EF, Mossman BT, Reynaert NL. Silica induces NLRP3 inflammasome activation in human lung epithelial cells. Part Fibre Toxicol. 2013;10:3. 91. Yang EJ, Kim S, Kim JS, Choi IH. Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles. Biomaterials. 2012;33(28):6858–6867. 92. Tomić S, Đokić J, Vasilijić S, et al. Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PLoS One. 2014;9(5):e96584. 93. Schanen BC, Das S, Reilly CM, et al. Immunomodulation and T helper TH\n1 /TH 2 response polarization by CeO 2 and TiO 2 nanoparticles. PLoS One. 2013;8(5):e62816. 94. Schanen BC, Karakoti AS, Seal S, Drake DR 3rd, Warren WL,\nSelf WT. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano. 2009;3(9): 2523–2532. 95. Ghoneum M, Ghoneum A, Gimzewski J. Nanodiamond and nanoplatinum liquid, DPV576, activates human monocyte-derived dendritic cells in vitro. Anticancer Res. 2010;30(10):4075–4079. 96. Dai X, Guo Q, Zhao Y, et al. Functional silver nanoparticle as a benign antimicrobial agent that eradicates antibiotic-resistant bacteria and promotes wound healing. ACS Appl Mater Interfaces. 2016;8(39): 25798–25807. 97. Bollenbach T. Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution. Curr Opin Microbiol. 2015;27:1–9. 98. Fischbach MA. Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol. 2011;14(5):519–523. 99. Panáček A, Smékalová M, Kilianová M, et al. Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect. Molecules. 2015;21(1):E26. 100. Naqvi SZ, Kiran U, Ali MI, et al. Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int J Nanomedicine. 2013;8: 3187–3195. 101. Thomas R, Nair AP, Kr S, Mathew J, Ek R. Antibacterial activity and synergistic effect of biosynthesized AgNPs with antibiotics against multidrug-resistant biofilm-forming coagulase-negative Staphylococci isolated from clinical samples. Appl Biochem Biotechnol. 2014;173(2): 449–460. 102. Hwang IS, Hwang JH, Choi H, Kim KJ, Lee DG. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J Med Microbiol. 2012;61(Pt 12):1719–1726. 103. Wan G, Ruan L, Yin Y, Yang T, Ge M, Cheng X. Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii. Int J Nanomedicine. 2016;11: 3789–3800. In te rn at io na l J ou rn al o f N an om ed ic in e do w nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n8224"
    }, {
      "heading" : "Hemeg",
      "text" : "104. Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME. Nanoparticles functionalized with ampicillin destroy multiple-antibioticresistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol. 2012;78(8):2768–2774. 105. Iram S, Akbar Khan J, Aman N, Nadhman A, Zulfiqar Z, Arfat Yameen M. Enhancing the anti-enterococci activity of different antibiotics by combining with metal oxide nanoparticles. Jundishapur J Microbiol. 2016;9(3):e31302. 106. Hur YE, Park Y. Vancomycin-functionalized gold and silver nanoparticles as an antibacterial nanoplatform against methicillinresistant Staphylococcus aureus. J Nanosci Nanotechnol. 2016;16(6): 6393–6399. 107. Kalhapure RS, Sonawane SJ, Sikwal DR, et al. Solid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSA. Colloids Surf B Biointerfaces. 2015;136:651–658. 108. Akram FE, El-Tayeb T, Abou-Aisha K, El-Azizi M. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). Ann Clin Microbiol Antimicrob. 2016;15(1):48. 109. Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P. γ-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol. J Inorg Biochem. 2016;157:15–24. 110. Gu H, Ho PL, Tong E, Wang L, Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 2003;3(9): 1261–1263. 111. Payne JN, Waghwani HK, Connor MG, et al. Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity. Front Microbiol. 2016;7:607. 112. Ghasemi F, Jalal R. Antimicrobial action of zinc oxide nanoparticles in combination with ciprofloxacin and ceftazidime against multidrugresistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2016; 6:118–122. 113. Gurunathan S. Biologically synthesized silver nanoparticles enhances antibiotic activity against gram-negative bacteria. J Ind Eng Chem. 2015;29:217–226. 114. Singh R, Wagh P, Wadhwani S, et al. Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics. Int J Nanomedicine. 2013;8:4277–4290. 115. Hari N, Thomas NK, Nair AAJ. Comparative study on the synergistic action of differentially synthesized silver nanoparticles with β-cephem antibiotics and chloramphenicol. J Nanosci. 2014;2014:201482. 116. Kalita S, Kandimalla R, Sharma KK, Kataki AC, Deka M, Kotoky J. Amoxicillin functionalized gold nanoparticles reverts MRSA resistance. Mater Sci Eng C Mater Biol Appl. 2016;61:720–727. 117. Ghosh IN, Patil SD, Sharma TK, Srivastava SK, Pathania R, Navani NK. Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications. Int J Nanomedicine. 2013;8:4721–4731. 118. Perugini Biasi-Garbin R, Saori Otaguiri E, Morey AT, et al. Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles. Evid Based Complement Alternat Med. 2015;2015:861497. 119. Huang X, Chen X, Chen Q, Yu Q, Sun D, Liu J. Investigation of functional selenium nanoparticles as potent antimicrobial agents against superbugs. Acta Biomater. 2016;30:397–407. 120. Park S, Cha SH, Cho I, et al. Antibacterial nanocarriers of resveratrol with gold and silver nanoparticles. Mater Sci Eng C Mater Biol Appl. 2016;58:1160–1169. 121. Scandorieiro S, de Camargo LC, Lancheros CA, et al. Synergistic and additive effect of oregano essential oil and biological silver nanoparticles against multidrug-resistant bacterial strains. Front Microbiol. 2016;7:760. 122. Manju S, Malaikozhundan B, Vijayakumar S, et al. Antibacterial, antibiofilm and cytotoxic effects of Nigella sativa essential oil coated gold nanoparticles. Microb Pathog. 2016;91:129–135. 123. Palza H. Antimicrobial polymers with metal nanoparticles. Int J Mol Sci. 2015;16(1):2099–2116. 124. Shurygina IA, Shurygin MG, Sukhov BG. Nanobiocomposites of metals as antimicrobial agents. In: Kon K, Rai M, editors. Antibiotic Resistance: Mechanisms and New Antimicrobial Approaches. Academic Press, Elsevier Inc., USA; 2016:167–182. 125. Esmailzadeh H, Sangpour P, Shahraz F, Hejazi J, Khaksar R. Effect of nanocomposite packaging containing ZnO on growth of Bacillus subtilis and Enterobacter aerogenes. Mater Sci Eng C Mater Biol Appl. 2016;58:1058–1063. 126. Ghaseminezhad SM, Shojaosadati SA. Evaluation of the antibacterial activity of Ag/Fe 3 O 4 nanocomposites synthesized using starch. Carbohydr Polym. 2016;144:454–463. 127. de Moraes AC, Lima BA, de Faria AF, Brocchi M, Alves OL. Graphene oxide-silver nanocomposite as a promising biocidal agent against methicillin-resistant Staphylococcus aureus. Int J Nanomedicine. 2015; 10:6847–6861. 128. Azevedo MM, Ramalho P, Silva AP, Teixeira-Santos R, Pina-Vaz C, Rodrigues AG. Polyethyleneimine and polyethyleneimine-based nanoparticles: novel bacterial and yeast biofilm inhibitors. J Med Microbiol. 2014;63(Pt 9):1167–1173. 129. Peng Y, Song C, Yang C, Guo Q, Yao M. Low molecular weight chitosan-coated silver nanoparticles are effective for the treatment of MRSA-infected wounds. Int J Nanomedicine. 2017;12:295–304. 130. Natarajan S, Bhuvaneshwari M, Lakshmi DS, Mrudula P, Chandrasekaran N, Mukherjee A. Antibacterial and antifouling activities of chitosan/TiO 2 /Ag NPs nanocomposite films against packaged drinking water bacterial isolates. Environ Sci Pollut Res Int. 2016;23(19):19529–19540. 131. Arjunan N, Kumari HL, Singaravelu CM, Kandasamy R, Kandasamy J. Physicochemical investigations of biogenic chitosan-silver nanocomposite as antimicrobial and anticancer agent. Int J Biol Macromol. 2016; 92:77–87. 132. Raut AV, Yadav HM, Gnanamani A, Pushpavanam S, Pawar SH. Synthesis and characterization of chitosan-TiO 2 :Cu nanocomposite and their enhanced antimicrobial activity with visible light. Colloids Surf B Biointerfaces. 2016;148:566–575. 133. El-Nahrawy AM, Ali AI, Abou Hammad AB, Youssef AM. Influences of Ag-NPs doping chitosan/calcium silicate nanocomposites for optical and antibacterial activity. Int J Biol Macromol. 2016; 93(Pt A):267–275. 134. Niska K, Knap N, Kędzia A, Jaskiewicz M, Kamysz W, InkielewiczStepniak I. Capping agent-dependent toxicity and antimicrobial activity of silver nanoparticles: an in vitro study. Concerns about potential application in dental practice. Int J Med Sci. 2016;13(10):772–782. 135. Takahashi C, Matsubara N, Akachi Y, et al. Visualization of silverdecorated poly (DL-lactide-co-glycolide) nanoparticles and their efficacy against Staphylococcus epidermidis. Mater Sci Eng C Mater Biol Appl. 2017;72:143–149. 136. Richter AP, Brown JS, Bharti B, et al. An environmentally benign antimicrobial nanoparticle based on a silver-infused lignin core. Nat Nanotechnol. 2015;10(9):817–823. 137. Mukherjee M, De S. Inactivation of Pseudomonas aeruginosa by chitosan coated iron oxide nanoparticles. Recent Pat Biotechnol. 2016; 10(1):133–139. 138. Govindaraju S, Samal M, Yun K. Superior antibacterial activity of GlcN-AuNP-GO by ultraviolet irradiation. Mater Sci Eng C Mater Biol Appl. 2016;69:366–372. 139. Kim DY, Kim M, Shinde S, Sung JS, Ghodake G. Cytotoxicity and antibacterial assessment of gallic acid capped gold nanoparticles. Colloids Surf B Biointerfaces. 2017;149:162–167. 140. Kuo YL, Wang SG, Wu CY, et al. Functional gold nanoparticle-based antibacterial agents for nosocomial and antibiotic-resistant bacteria. Nanomedicine (Lond). 2016;11(19):2497–2510. In te rn at io na l J ou rn al o f N an om ed ic in e do w nl oa de d fr om h ttp s: //w w w .d ov ep re ss .c om / b y 17 8. 15 9. 10 0. 16 8 on 2 7- Ju l-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1\nInternational Journal of Nanomedicine\nPublish your work in this journal\nSubmit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal\nThe International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\nDovepress\n8225\nNanomaterials as antibacterial agents\n141. Gahlawat G, Shikha S, Chaddha BS, Chaudhuri SM, Mayilraj S, Choudhury AR. Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera. Microb Cell Fact. 2016;15:25. 142. Pornpattananangkul D, Zhang L, Olson S, et al. Bacterial toxintriggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133(11): 4132–4139. 143. Mu H, Tang J, Liu Q, Sun C, Wang T, Duan J. Potent antibacterial nanoparticles against biofilm and intracellular bacteria. Sci Rep. 2016;6:18877.\nIn\nte rn\nat io\nna l J\nou rn\nal o\nf N an\nom ed\nic in\ne do\nw nl\noa de\nd fr\nom h\nttp s:\n//w w\nw .d\nov ep\nre ss\n.c om\n/ b y\n17 8.\n15 9.\n10 0.\n16 8\non 2\n7- Ju\nl-2 01 8 F or p er so na l u se o nl y.\nPowered by TCPDF (www.tcpdf.org)\n1 / 1"
    } ],
    "references" : [ {
      "title" : "Infections caused by Acinetobacter baumannii in recipients of hematopoietic stem cell transplantation",
      "author" : [ "Al-Anazi KA", "Al-Jasser AM" ],
      "venue" : "Front Oncol",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2014
    }, {
      "title" : "Complement c5a generation by staphylococcal biofilms",
      "author" : [ "AE Satorius", "J Szafranski", "D Pyne" ],
      "venue" : null,
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2013
    }, {
      "title" : "Gene expression analysis in human polymorphonuclear leukocytes stimulated by LPSs from nosocomial opportunistic pathogens",
      "author" : [ "T Ubagai", "R Nakano", "A Nakano", "G Kamoshida", "Y. Ono" ],
      "venue" : "Innate Immun",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2015
    }, {
      "title" : "Antimicrobial resistance patterns of Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus isolated from patients with nosocomial infections admitted to Tehran Hospitals",
      "author" : [ "F Fallah", "H Abdolghafoorian", "RS Sajadi Nia" ],
      "venue" : "Arch Pediatr Infect Dis",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2015
    }, {
      "title" : "Alternative antimicrobial approach: nano-antimicrobial materials",
      "author" : [ "N Beyth", "Y Houri-Haddad", "A Domb", "W Khan", "R. Hazan" ],
      "venue" : "Evid Based Complement Alternat Med",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2015
    }, {
      "title" : "Nanoparticle-based antimicrobials: surface functionality is critical. F1000Res. 2016;5:F1000 Faculty Rev-364",
      "author" : [ "A Gupta", "RF Landis", "VM. Rotello" ],
      "venue" : null,
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2016
    }, {
      "title" : "Nanotechnology as a therapeutic tool to combat microbial resistance",
      "author" : [ "Pelgrift RY", "Friedman AJ" ],
      "venue" : "Adv Drug Deliv Rev",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2013
    }, {
      "title" : "Antibiotic resistance: can nanoparticles tackle the problem",
      "author" : [ "M Rai", "K Kon", "A Gade" ],
      "venue" : null,
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2016
    }, {
      "title" : "An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii",
      "author" : [ "L Dijkshoorn", "A Nemec", "H. Seifert" ],
      "venue" : "Nat Rev Microbiol",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2007
    }, {
      "title" : "Nosocomial outbreak of extensively and pan drug-resistant Acinetobacter baumannii in tertiary hospital in central part of Iran",
      "author" : [ "A Japoni-Nejad", "M Sofian", "A van Belkum", "E. Ghaznavi-Rad" ],
      "venue" : "Jundishapur J Microbiol",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2013
    }, {
      "title" : "Prevalence and resistance profile of Acinetobacter baumannii clinical isolates from a private hospital in Khartoum, Sudan",
      "author" : [ "MI Omer", "SA Gumaa", "AA Hassan" ],
      "venue" : "Am J Microbiol Res",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2015
    }, {
      "title" : "Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia",
      "author" : [ "R Aljindan", "H Bukharie", "A Alomar", "B. Abdalhamid" ],
      "venue" : "J Med Microbiol",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2015
    }, {
      "title" : "The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit",
      "author" : [ "P Cornejo-Juárez", "D Vilar-Compte", "C Pérez-Jiménez", "SA ÑamendysSilva", "S Sandoval-Hernández", "P. Volkow-Fernández" ],
      "venue" : "Int J Infect Dis",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2015
    }, {
      "title" : "The antibiotic resistance crisis: part 1: causes and threats. PT",
      "author" : [ "Ventola CL" ],
      "venue" : null,
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2015
    }, {
      "title" : "Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics",
      "author" : [ "D Lebeaux", "JM Ghigo", "C. Beloin" ],
      "venue" : "Microbiol Mol Biol Rev",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2014
    }, {
      "title" : "Mechanisms and consequences of bacterial resistance to antimicrobial peptides",
      "author" : [ "DI Andersson", "D Hughes", "JZ. Kubicek-Sutherland" ],
      "venue" : "Drug Resist Updat",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2016
    }, {
      "title" : "Debugging how bacteria manipulate the immune response",
      "author" : [ "Sansonetti PJ", "Di Santo JP" ],
      "venue" : null,
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2007
    }, {
      "title" : "Antibiotic resistance mechanisms of clinically important bacteria",
      "author" : [ "A Giedraitienė", "A Vitkauskienė", "R Naginienė", "A. Pavilonis" ],
      "venue" : "Medicina (Kaunas)",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2011
    }, {
      "title" : "Antimicrobial Drug Resistance: Volume 1. Mechanisms of Drug Resistance",
      "author" : [ "Mayers D", "editor" ],
      "venue" : "Infectious Disease. Humana Press,",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2009
    }, {
      "title" : "Multidrug efflux pumps at the crossroad between antibiotic resistance and bacterial virulence",
      "author" : [ "M Alcalde-Rico", "S Hernando-Amado", "P Blanco", "JL. Martínez" ],
      "venue" : "Front Microbiol",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2016
    }, {
      "title" : "Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment",
      "author" : [ "S Shaikh", "J Fatima", "S Shakil", "SM Rizvi", "MA. Kamal" ],
      "venue" : "Saudi J Biol Sci",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2015
    }, {
      "title" : "Molecular mechanisms of antibiotic resistance",
      "author" : [ "JM Blair", "MA Webber", "AJ Baylay", "DO Ogbolu", "LJ. Piddock" ],
      "venue" : "Nat Rev Microbiol",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2017
    }, {
      "title" : "Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2′′)-la",
      "author" : [ "G Cox", "PJ Stogios", "A Savchenko", "GD. Wright" ],
      "venue" : "MBio",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2015
    }, {
      "title" : "Catalysis and sulfa drug resistance in dihydropteroate synthase: crystal structures reveal the catalytic mechanism of DHPS and the structural basis of sulfa drug action and resistance",
      "author" : [ "MK Yun", "Y Wu", "Z Li" ],
      "venue" : null,
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2012
    }, {
      "title" : "Nanomedicine in the management of microbial infection – overview and perspectives",
      "author" : [ "X Zhu", "AF Radovic-Moreno", "J Wu", "R Langer", "J. Shi" ],
      "venue" : "Nano Today",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2014
    }, {
      "title" : "Antimicrobial activity of the metals and metal oxide nanoparticles",
      "author" : [ "SM Dizaj", "F Lotfipour", "M Barzegar-Jalali", "MH Zarrintan", "K. Adibkia" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2014;44:278–284",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2014
    }, {
      "title" : "Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm",
      "author" : [ "R Hernandez-Delgadillo", "D Velasco-Arias", "D Diaz" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2012
    }, {
      "title" : "Mechanistic basis of antimicrobial actions of silver nanoparticles",
      "author" : [ "TC Dakal", "A Kumar", "RS Majumdar", "V. Yadav" ],
      "venue" : "Front Microbiol",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2016
    }, {
      "title" : "Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity",
      "author" : [ "N Durán", "M Durán", "MB de Jesus", "AB Seabra", "WJ Fávaro", "G. Nakazato" ],
      "venue" : "Nanomedicine",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2016
    }, {
      "title" : "Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria",
      "author" : [ "MK Rai", "SD Deshmukh", "AP Ingle", "AK. Gade" ],
      "venue" : "J Appl Microbiol",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2012
    }, {
      "title" : "Rapid evolution of silver nanoparticle resistance in Escherichia coli",
      "author" : [ "Jr Graves JL", "M Tajkarimi", "Q Cunningham" ],
      "venue" : "Front Genet",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2015
    }, {
      "title" : "Interaction of Al (2)  O (3)  nanoparticles with Escherichia coli and their cell envelope biomolecules",
      "author" : [ "MA Ansari", "HM Khan", "AA Khan", "SS Cameotra", "Q Saquib", "J. Musarrat" ],
      "venue" : "J Appl Microbiol",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2014
    }, {
      "title" : "Molecular mechanism and targets of the antimicrobial activity of metal nanoparticles",
      "author" : [ "FN Oktar", "M Yetmez", "D Ficai", "A Ficai", "F Dumitru", "A. Pica" ],
      "venue" : null,
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2015
    }, {
      "title" : "The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp",
      "author" : [ "ME Łysakowska", "A Ciebiada-Adamiec", "L Klimek", "M. Sienkiewicz" ],
      "venue" : null,
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2015
    }, {
      "title" : "Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism",
      "author" : [ "A Sirelkhatim", "S Mahmud", "A Seeni" ],
      "venue" : null,
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2015
    }, {
      "title" : "Antibacterial property of Ag nanoparticle-impregnated N-doped titania films under visible light",
      "author" : [ "MS Wong", "CW Chen", "CC Hsieh", "SC Hung", "DS Sun", "HH. Chang" ],
      "venue" : null,
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 1978
    }, {
      "title" : "Mechanism of antibacterial activity of copper nanoparticles",
      "author" : [ "AK Chatterjee", "R Chakraborty", "T. Basu" ],
      "venue" : "Nanotechnology",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2014
    }, {
      "title" : "Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles",
      "author" : [ "J Lellouche", "A Friedman", "R Lahmi", "A Gedanken", "E. Banin" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2012
    }, {
      "title" : "Silver nanoparticles as potential antibacterial agents",
      "author" : [ "G Franci", "A Falanga", "S Galdiero" ],
      "venue" : null,
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2015
    }, {
      "title" : "Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles",
      "author" : [ "KY Yoon", "J Hoon Byeon", "JH Park", "J. Hwang" ],
      "venue" : "Sci Total Environ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2007
    }, {
      "title" : "Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen",
      "author" : [ "S Shamaila", "N Zafar", "S Riaz", "R Sharif", "J Nazir", "S. Naseem" ],
      "venue" : "Nanomaterials (Basel)",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2016
    }, {
      "title" : "Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. Nanoscale",
      "author" : [ "Y Luo", "M Hossain", "C Wang" ],
      "venue" : null,
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2013
    }, {
      "title" : "Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure",
      "author" : [ "S Huo", "Y Jiang", "A Gupta" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2016
    }, {
      "title" : "Synthesis, characterization and antibacterial activity of colloidal NiO nanoparticles",
      "author" : [ "KS Khashan", "GM Sulaiman", "FA Abdul Ameer", "G. Napolitano" ],
      "venue" : "Pak J Pharm Sci",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2016
    }, {
      "title" : "Synthesis, characterization and antimicrobial activity of Ce doped TiO 2  nanoparticles",
      "author" : [ "Z Ali", "B Raj", "M Vishwas", "MA. Athhar" ],
      "venue" : "Int J Curr Microbiol Appl Sci",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2016
    }, {
      "title" : "Medical biofilms–nanotechnology approaches",
      "author" : [ "S Neethirajan", "MA Clond", "A. Vogt" ],
      "venue" : "J Biomed Nanotechnol",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2014
    }, {
      "title" : "ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production",
      "author" : [ "JH Lee", "YG Kim", "MH Cho", "J. Lee" ],
      "venue" : "Microbiol Res",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2014
    }, {
      "title" : "Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles",
      "author" : [ "J Lellouche", "A Friedman", "A Gedanken", "E. Banin" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2012
    }, {
      "title" : "Inhibition of E. coli and S. aureus with selenium nanoparticles synthesized by pulsed laser ablation in deionized water",
      "author" : [ "G Guisbiers", "Q Wang", "E Khachatryan" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 2016
    }, {
      "title" : "Microemulsion mediated synthesis and characterization of CdS nanoparticles and its anti-biofilm efficacy against Escherichia coli ATCC 25922",
      "author" : [ "K Dhanabalan", "K. Gurunathan" ],
      "venue" : "J Nanosci Nanotechnol",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2015
    }, {
      "title" : "Magnetite nanostructures as novel strategies for anti-infectious therapy",
      "author" : [ "I Liakos", "AM Grumezescu", "AM. Holban" ],
      "venue" : null,
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2014
    }, {
      "title" : "In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa",
      "author" : [ "S Nour El Din", "TA El-Tayeb", "K Abou-Aisha", "M. El-Azizi" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2016
    }, {
      "title" : "Effects of different surface modifying agents on the cytotoxic and antimicrobial properties of ZnO nanoparticles",
      "author" : [ "SC Esparza-González", "S Sánchez-Valdés", "SN Ramírez-Barrón" ],
      "venue" : "Toxicol In Vitro",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2016
    }, {
      "title" : "Nanobiomaterials in Antimicrobial Therapy: Applications of Nanobiomaterials",
      "author" : [ "Grumezescu A", "editor" ],
      "venue" : "1st ed. Elsevier,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2016
    }, {
      "title" : "Ag and Cu monometallic and Ag/Cu bimetallic nanoparticle-graphene composites with enhanced antibacterial performance",
      "author" : [ "A Perdikaki", "A Galeou", "G Pilatos" ],
      "venue" : "ACS Appl Mater Interfaces. Epub 2016 Oct",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2016
    }, {
      "title" : "Copper/zinc bimetal nanoparticlesdispersed carbon nanofibers: a novel potential antibiotic material",
      "author" : [ "M Ashfaq", "N Verma", "S. Khan" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2016;59:938–947",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2016
    }, {
      "title" : "New paradigm shift for the green synthesis of antibacterial silver nanoparticles utilizing plant extracts",
      "author" : [ "Y. Park" ],
      "venue" : "Toxicol Res",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2014
    }, {
      "title" : "Biological synthesis of silver nanoparticles and its antibacterial activity",
      "author" : [ "H Gandhi", "S. Khan" ],
      "venue" : "J Nanomed Nanotechnol",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2016
    }, {
      "title" : "Rosmarinus officinalis leaf extract mediated green synthesis of silver nanoparticles and investigation of its antimicrobial properties",
      "author" : [ "M Ghaedi", "M Yousefinejad", "M Safarpoor", "HZ Khafri", "MK. Purkait" ],
      "venue" : "J Ind Eng Chem",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2015
    }, {
      "title" : "Bark extract mediated green synthesis of silver nanoparticles: evaluation of antimicrobial activity and antiproliferative response against osteosarcoma",
      "author" : [ "D Nayak", "S Ashe", "PR Rauta", "M Kumari", "B. Nayak" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2016;58:44–52",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2016
    }, {
      "title" : "Green synthesis of silver nanoparticles using leaves extract of Skimmia laureola: characterization and antibacterial activity",
      "author" : [ "MJ Ahmed", "G Murtaza", "A Mehmood", "TM. Bhatti" ],
      "venue" : null,
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2015
    }, {
      "title" : "Green synthesis of silver nanoparticles using Delphinium denudatum root extract exhibits antibacterial and mosquito larvicidal activities",
      "author" : [ "G Suresh", "PH Gunasekar", "D Kokila" ],
      "venue" : "Spectrochim Acta A Mol Biomol Spectrosc",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2014
    }, {
      "title" : "Antibacterial, anti-biofilm and anticancer potentials of green synthesized silver nanoparticles using benzoin gum (Styrax benzoin) extract",
      "author" : [ "J Du", "H Singh", "TH. Yi" ],
      "venue" : "Bioprocess Biosyst Eng",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2016
    }, {
      "title" : "Development of biogenic silver nanoparticle using Rosa chinensis flower extract and its antibacterial property",
      "author" : [ "Y Meng", "Y. Sun" ],
      "venue" : "J Nanosci Nanotechnol",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2016
    }, {
      "title" : "Silver nanoparticles synthesized using Caesalpinia sappan extract as potential novel nanoantibiotics against methicillin-resistant Staphylococcus aureus",
      "author" : [ "SH Jun", "SH Cha", "JH Kim", "M Yoon", "S Cho", "Y. Park" ],
      "venue" : "J Nanosci Nanotechnol",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2015
    }, {
      "title" : "Green synthesis of silver nanoparticles using Coffea arabica seed extract and its antibacterial activity",
      "author" : [ "V Dhand", "L Soumya", "S Bharadwaj", "S Chakra", "D Bhatt", "B. Sreedhar" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2017
    }, {
      "title" : "Green synthesis of ZnO nanoparticles using Solanum nigrum leaf extract and their antibacterial activity",
      "author" : [ "M Ramesh", "M Anbuvannan", "G. Viruthagiri" ],
      "venue" : "Spectrochim Acta A Mol Biomol Spectrosc",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2015
    }, {
      "title" : "Antimicrobial potential of green synthesized CeO 2  nanoparticles from Olea europaea leaf extract",
      "author" : [ "Q Maqbool", "M Nazar", "S Naz" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2016
    }, {
      "title" : "A novel green synthesis of Fe 3  O 4  -Ag core shell recyclable nanoparticles using Vitis vinifera stem extract and its enhanced antibacterial",
      "author" : [ "S Venkateswarlu", "BN Kumar", "B Prathima", "K Anitha", "NVV. Jyothi" ],
      "venue" : null,
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2015
    }, {
      "title" : "Green synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activity",
      "author" : [ "P Tippayawat", "N Phromviyo", "P Boueroy", "A. Chompoosor" ],
      "venue" : "PeerJ. 2016;4:e2589",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2016
    }, {
      "title" : "Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa",
      "author" : [ "K Singh", "M Panghal", "S Kadyan", "U Chaudhary", "JP. Yadav" ],
      "venue" : "J Nanobiotechnology",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2014
    }, {
      "title" : "Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa",
      "author" : [ "N Mapara", "M Sharma", "V Shriram", "R Bharadwaj", "KC Mohite", "V. Kumar" ],
      "venue" : "Appl Microbiol Biotechnol",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2015
    }, {
      "title" : "Antibacterial properties of cetyltrimethylammonium bromide-stabilized green silver nanoparticles against methicillin-resistant Staphylococcus aureus",
      "author" : [ "H Jang", "SH Lim", "JS Choi", "Y. Park" ],
      "venue" : "Arch Pharm Res",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2015
    }, {
      "title" : "Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against water borne pathogens",
      "author" : [ "C Krishnaraj", "EG Jagan", "S Rajasekar", "P Selvakumar", "PT Kalaichelvan", "N. Mohan" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2010
    }, {
      "title" : "Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of Gram-Negative Bacteria viz. Escherichia coli and Pseudomonas aeruginosa",
      "author" : [ "B Ramalingam", "T Parandhaman", "SK. Das" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2016
    }, {
      "title" : "Green synthesis of silver nanoparticles from the extract of the inflorescence of Cocos nucifera (Family: Arecaceae) for enhanced antibacterial activity",
      "author" : [ "R Mariselvam", "AJ Ranjitsingh", "A Usha Raja Nanthini", "K Kalirajan", "C Padmalatha", "P. Mosae Selvakumar" ],
      "venue" : "Spectrochim Acta A Mol Biomol Spectrosc",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2014
    }, {
      "title" : "Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli",
      "author" : [ "W Salem", "DR Leitner", "FG Zingl" ],
      "venue" : "Int J Med Microbiol",
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2015
    }, {
      "title" : "Novel green synthesis of gold nanoparticles using Citrullus lanatus rind and investigation of proteasome inhibitory activity, antibacterial, and antioxidant potential",
      "author" : [ "Patra JK", "Baek KH" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 2015
    }, {
      "title" : "Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control",
      "author" : [ "GR Salunke", "S Ghosh", "RJ Santosh Kumar" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2014
    }, {
      "title" : "Green synthesis of silver, gold and silver/gold bimetallic nanoparticles using the Gloriosa superba leaf extract and their antibacterial and antibiofilm activities",
      "author" : [ "K Gopinath", "S Kumaraguru", "K Bhakyaraj" ],
      "venue" : "Microb Pathog",
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2016
    }, {
      "title" : "Screening antimicrobial activity of nickel nanoparticles synthesized using Ocimum sanctum leaf extract",
      "author" : [ "CJ Pandian", "R Palanivel", "S. Dhanasekaran" ],
      "venue" : "J Nanoparticles",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2016
    }, {
      "title" : "Green synthesis of Al 2  O 3 nanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa",
      "author" : [ "MA Ansari", "HM Khan", "MA Alzohairy" ],
      "venue" : "World J Microbiol Biotechnol",
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2015
    }, {
      "title" : "Biosynthesis of palladium nanoparticles by using Moringa oleifera flower extract and their catalytic and biological properties",
      "author" : [ "K Anand", "C Tiloke", "A Phulukdaree" ],
      "venue" : "J Photochem Photobiol B",
      "citeRegEx" : "83",
      "shortCiteRegEx" : "83",
      "year" : 2016
    }, {
      "title" : "Antimicrobial and antibiofilm effects of selenium nanoparticles on some foodborne pathogens",
      "author" : [ "Khiralla GM", "El-Deeb BA" ],
      "venue" : "LWT – Food Sci Technol",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2015
    }, {
      "title" : "Biogenic selenium nanoparticles inhibit Staphylococcus aureus adherence on different surfaces",
      "author" : [ "P Sonkusre", "S. Singh Cameotra" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2015
    }, {
      "title" : "Metal-based nanoparticles and the immune system: activation, inflammation, and potential applications",
      "author" : [ "YH Luo", "LW Chang", "P. Lin" ],
      "venue" : "Biomed Res",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2015
    }, {
      "title" : "Immunomodulation of nanoparticles in nanomedicine applications",
      "author" : [ "Q Jiao", "L Li", "Q Mu", "Q. Zhang" ],
      "venue" : "Biomed Res Int",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2014
    }, {
      "title" : "The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction",
      "author" : [ "C Hanley", "A Thurber", "C Hanna", "A Punnoose", "J Zhang", "DG. Wingett" ],
      "venue" : "Nanoscale Res Lett",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2009
    }, {
      "title" : "Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β",
      "author" : [ "AS Yazdi", "G Guarda", "N Riteau" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2010
    }, {
      "title" : "Silica induces NLRP3 inflammasome activation in human lung epithelial cells",
      "author" : [ "PM Peeters", "TN Perkins", "EF Wouters", "BT Mossman", "NL. Reynaert" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2013
    }, {
      "title" : "Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles",
      "author" : [ "EJ Yang", "S Kim", "JS Kim", "IH. Choi" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2012
    }, {
      "title" : "Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro",
      "author" : [ "S Tomić", "J Đokić", "S Vasilijić" ],
      "venue" : "PLoS One",
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2014
    }, {
      "title" : "Immunomodulation and T helper TH 1 /TH 2 response polarization by CeO 2 and TiO 2  nanoparticles",
      "author" : [ "BC Schanen", "S Das", "CM Reilly" ],
      "venue" : "PLoS One",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2013
    }, {
      "title" : "Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct",
      "author" : [ "BC Schanen", "AS Karakoti", "S Seal", "3rd Drake DR", "WL Warren", "WT. Self" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2009
    }, {
      "title" : "Nanodiamond and nanoplatinum liquid, DPV576, activates human monocyte-derived dendritic cells in vitro",
      "author" : [ "M Ghoneum", "A Ghoneum", "J. Gimzewski" ],
      "venue" : "Anticancer Res",
      "citeRegEx" : "95",
      "shortCiteRegEx" : "95",
      "year" : 2010
    }, {
      "title" : "Functional silver nanoparticle as a benign antimicrobial agent that eradicates antibiotic-resistant bacteria and promotes wound healing",
      "author" : [ "X Dai", "Q Guo", "Y Zhao" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "96",
      "shortCiteRegEx" : "96",
      "year" : 2016
    }, {
      "title" : "Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution",
      "author" : [ "T. Bollenbach" ],
      "venue" : "Curr Opin Microbiol",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2015
    }, {
      "title" : "Combination therapies for combating antimicrobial resistance",
      "author" : [ "Fischbach MA" ],
      "venue" : "Curr Opin Microbiol",
      "citeRegEx" : "98",
      "shortCiteRegEx" : "98",
      "year" : 2011
    }, {
      "title" : "Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect",
      "author" : [ "A Panáček", "M Smékalová", "M Kilianová" ],
      "venue" : null,
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2015
    }, {
      "title" : "Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria",
      "author" : [ "SZ Naqvi", "U Kiran", "MI Ali" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2013
    }, {
      "title" : "Antibacterial activity and synergistic effect of biosynthesized AgNPs with antibiotics against multidrug-resistant biofilm-forming coagulase-negative Staphylococci isolated from clinical samples",
      "author" : [ "R Thomas", "AP Nair", "S Kr", "J Mathew", "R. Ek" ],
      "venue" : "Appl Biochem Biotechnol",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2014
    }, {
      "title" : "Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved",
      "author" : [ "IS Hwang", "JH Hwang", "H Choi", "KJ Kim", "DG. Lee" ],
      "venue" : "J Med Microbiol",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2012
    }, {
      "title" : "Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii",
      "author" : [ "G Wan", "L Ruan", "Y Yin", "T Yang", "M Ge", "X. Cheng" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2017
    }, {
      "title" : "Nanoparticles functionalized with ampicillin destroy multiple-antibioticresistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus",
      "author" : [ "AN Brown", "K Smith", "TA Samuels", "J Lu", "SO Obare", "ME. Scott" ],
      "venue" : "Appl Environ Microbiol",
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2012
    }, {
      "title" : "Enhancing the anti-enterococci activity of different antibiotics by combining with metal oxide nanoparticles",
      "author" : [ "S Iram", "J Akbar Khan", "N Aman", "A Nadhman", "Z Zulfiqar", "M. Arfat Yameen" ],
      "venue" : "Jundishapur J Microbiol",
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2016
    }, {
      "title" : "Vancomycin-functionalized gold and silver nanoparticles as an antibacterial nanoplatform against methicillinresistant Staphylococcus aureus",
      "author" : [ "YE Hur", "Y. Park" ],
      "venue" : "J Nanosci Nanotechnol",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2016
    }, {
      "title" : "Solid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSA",
      "author" : [ "RS Kalhapure", "SJ Sonawane", "DR Sikwal" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2015
    }, {
      "title" : "A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)",
      "author" : [ "FE Akram", "T El-Tayeb", "K Abou-Aisha", "M. El-Azizi" ],
      "venue" : "Ann Clin Microbiol Antimicrob",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2016
    }, {
      "title" : "γ-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol",
      "author" : [ "R Gannimani", "M Ramesh", "S Mtambo", "K Pillay", "ME Soliman", "P. Govender" ],
      "venue" : "J Inorg Biochem",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 2016
    }, {
      "title" : "Presenting vancomycin on nanoparticles to enhance antimicrobial activities",
      "author" : [ "H Gu", "PL Ho", "E Tong", "L Wang", "B. Xu" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2003
    }, {
      "title" : "Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity",
      "author" : [ "JN Payne", "HK Waghwani", "MG Connor" ],
      "venue" : "Front Microbiol",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2016
    }, {
      "title" : "Antimicrobial action of zinc oxide nanoparticles in combination with ciprofloxacin and ceftazidime against multidrugresistant Acinetobacter baumannii",
      "author" : [ "F Ghasemi", "R. Jalal" ],
      "venue" : "J Glob Antimicrob Resist",
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2016
    }, {
      "title" : "Biologically synthesized silver nanoparticles enhances antibiotic activity against gram-negative bacteria",
      "author" : [ "S. Gurunathan" ],
      "venue" : "J Ind Eng Chem",
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2015
    }, {
      "title" : "Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics",
      "author" : [ "R Singh", "P Wagh", "S Wadhwani" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2013
    }, {
      "title" : "Comparative study on the synergistic action of differentially synthesized silver nanoparticles with β-cephem antibiotics and chloramphenicol",
      "author" : [ "N Hari", "NK Thomas", "AAJ. Nair" ],
      "venue" : "J Nanosci",
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2014
    }, {
      "title" : "Amoxicillin functionalized gold nanoparticles reverts MRSA resistance",
      "author" : [ "S Kalita", "R Kandimalla", "KK Sharma", "AC Kataki", "M Deka", "J. Kotoky" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2016;61:720–727",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2016
    }, {
      "title" : "Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications",
      "author" : [ "IN Ghosh", "SD Patil", "TK Sharma", "SK Srivastava", "R Pathania", "NK. Navani" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2013
    }, {
      "title" : "Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles",
      "author" : [ "R Perugini Biasi-Garbin", "E Saori Otaguiri", "AT Morey" ],
      "venue" : "Evid Based Complement Alternat Med",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2015
    }, {
      "title" : "Investigation of functional selenium nanoparticles as potent antimicrobial agents against superbugs",
      "author" : [ "X Huang", "X Chen", "Q Chen", "Q Yu", "D Sun", "J. Liu" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2016
    }, {
      "title" : "Antibacterial nanocarriers of resveratrol with gold and silver nanoparticles",
      "author" : [ "S Park", "SH Cha", "I Cho" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2016;58:1160–1169",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2016
    }, {
      "title" : "Synergistic and additive effect of oregano essential oil and biological silver nanoparticles against multidrug-resistant bacterial strains",
      "author" : [ "S Scandorieiro", "LC de Camargo", "CA Lancheros" ],
      "venue" : "Front Microbiol",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2016
    }, {
      "title" : "Antibacterial, antibiofilm and cytotoxic effects of Nigella sativa essential oil coated gold nanoparticles",
      "author" : [ "S Manju", "B Malaikozhundan", "S Vijayakumar" ],
      "venue" : "Microb Pathog",
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2016
    }, {
      "title" : "Antimicrobial polymers with metal nanoparticles",
      "author" : [ "H. Palza" ],
      "venue" : "Int J Mol Sci",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2015
    }, {
      "title" : "Nanobiocomposites of metals as antimicrobial agents",
      "author" : [ "IA Shurygina", "MG Shurygin", "BG. Sukhov" ],
      "venue" : null,
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2016
    }, {
      "title" : "Effect of nanocomposite packaging containing ZnO on growth of Bacillus subtilis and Enterobacter aerogenes",
      "author" : [ "H Esmailzadeh", "P Sangpour", "F Shahraz", "J Hejazi", "R. Khaksar" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2016;58:1058–1063",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2016
    }, {
      "title" : "Evaluation of the antibacterial activity of Ag/Fe 3  O 4  nanocomposites synthesized using starch",
      "author" : [ "Ghaseminezhad SM", "Shojaosadati SA" ],
      "venue" : "Carbohydr Polym",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2016
    }, {
      "title" : "Graphene oxide-silver nanocomposite as a promising biocidal agent against methicillin-resistant Staphylococcus aureus",
      "author" : [ "AC de Moraes", "BA Lima", "AF de Faria", "M Brocchi", "OL. Alves" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "127",
      "shortCiteRegEx" : "127",
      "year" : 2015
    }, {
      "title" : "Polyethyleneimine and polyethyleneimine-based nanoparticles: novel bacterial and yeast biofilm inhibitors",
      "author" : [ "MM Azevedo", "P Ramalho", "AP Silva", "R Teixeira-Santos", "C Pina-Vaz", "AG. Rodrigues" ],
      "venue" : "J Med Microbiol",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2014
    }, {
      "title" : "Low molecular weight chitosan-coated silver nanoparticles are effective for the treatment of MRSA-infected wounds",
      "author" : [ "Y Peng", "C Song", "C Yang", "Q Guo", "M. Yao" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 2017
    }, {
      "title" : "Antibacterial and antifouling activities of chitosan/TiO 2  /Ag NPs nanocomposite films against packaged drinking water bacterial isolates",
      "author" : [ "S Natarajan", "M Bhuvaneshwari", "DS Lakshmi", "P Mrudula", "N Chandrasekaran", "A. Mukherjee" ],
      "venue" : null,
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 1954
    }, {
      "title" : "Physicochemical investigations of biogenic chitosan-silver nanocomposite as antimicrobial and anticancer agent",
      "author" : [ "N Arjunan", "HL Kumari", "CM Singaravelu", "R Kandasamy", "J. Kandasamy" ],
      "venue" : "Int J Biol Macromol",
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2016
    }, {
      "title" : "Synthesis and characterization of chitosan-TiO 2  :Cu nanocomposite and their enhanced antimicrobial activity with visible light",
      "author" : [ "AV Raut", "HM Yadav", "A Gnanamani", "S Pushpavanam", "SH. Pawar" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2016
    }, {
      "title" : "Influences of Ag-NPs doping chitosan/calcium silicate nanocomposites for optical and antibacterial activity",
      "author" : [ "AM El-Nahrawy", "AI Ali", "AB Abou Hammad", "AM. Youssef" ],
      "venue" : "Int J Biol Macromol. 2016;",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2016
    }, {
      "title" : "Capping agent-dependent toxicity and antimicrobial activity of silver nanoparticles: an in vitro study. Concerns about potential application in dental practice",
      "author" : [ "K Niska", "N Knap", "A Kędzia", "M Jaskiewicz", "W Kamysz", "I. InkielewiczStepniak" ],
      "venue" : "Int J Med Sci",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2016
    }, {
      "title" : "Visualization of silverdecorated poly (DL-lactide-co-glycolide) nanoparticles and their efficacy against Staphylococcus epidermidis",
      "author" : [ "C Takahashi", "N Matsubara", "Y Akachi" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2017;72:143–149",
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2017
    }, {
      "title" : "An environmentally benign antimicrobial nanoparticle based on a silver-infused lignin",
      "author" : [ "AP Richter", "JS Brown", "B Bharti" ],
      "venue" : "core. Nat Nanotechnol",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 2015
    }, {
      "title" : "Inactivation of Pseudomonas aeruginosa by chitosan coated iron oxide nanoparticles",
      "author" : [ "M Mukherjee", "S. De" ],
      "venue" : "Recent Pat Biotechnol",
      "citeRegEx" : "137",
      "shortCiteRegEx" : "137",
      "year" : 2016
    }, {
      "title" : "Superior antibacterial activity of GlcN-AuNP-GO by ultraviolet irradiation",
      "author" : [ "S Govindaraju", "M Samal", "K. Yun" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl. 2016;69:366–372",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2016
    }, {
      "title" : "Cytotoxicity and antibacterial assessment of gallic acid capped gold nanoparticles",
      "author" : [ "DY Kim", "M Kim", "S Shinde", "JS Sung", "G. Ghodake" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2017
    }, {
      "title" : "Functional gold nanoparticle-based antibacterial agents for nosocomial and antibiotic-resistant bacteria. Nanomedicine (Lond)",
      "author" : [ "YL Kuo", "SG Wang", "CY Wu" ],
      "venue" : "Scopus and the Elsevier Bibliographic databases",
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 2017
    }, {
      "title" : "Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera",
      "author" : [ "G Gahlawat", "S Shikha", "BS Chaddha", "SM Chaudhuri", "S Mayilraj", "AR. Choudhury" ],
      "venue" : "Microb Cell Fact",
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2016
    }, {
      "title" : "Bacterial toxintriggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection",
      "author" : [ "D Pornpattananangkul", "L Zhang", "S Olson" ],
      "venue" : "J Am Chem Soc",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2011
    }, {
      "title" : "Potent antibacterial nanoparticles against biofilm and intracellular bacteria",
      "author" : [ "H Mu", "J Tang", "Q Liu", "C Sun", "T Wang", "J. Duan" ],
      "venue" : "Sci Rep. 2016;6:18877",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2016
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Introduction Hospital-acquired bacterial infections, mainly caused by the nosocomial pathogens such as Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and so on, pose the foremost challenge to the well-being of a patient.(1) The bacteria counteracts the host’s innate immune defense machinery,(2,3) which becomes the prime cause of death in patients confined to the intensive care unit (ICU), with weakened immune system, culminating in invasive bloodstream infections.",
      "startOffset" : 285,
      "endOffset" : 288
    }, {
      "referenceID" : 5,
      "context" : "when administered alone, hence overcoming the problem of resistance and diminishing other undesirable side effects to some extent.(6,8) There has also been a paradigm shift in management of biofilms and MDR bacteria with polymeric nanocomposites and antibiotic-loaded polymeric NPs.",
      "startOffset" : 130,
      "endOffset" : 135
    }, {
      "referenceID" : 7,
      "context" : "when administered alone, hence overcoming the problem of resistance and diminishing other undesirable side effects to some extent.(6,8) There has also been a paradigm shift in management of biofilms and MDR bacteria with polymeric nanocomposites and antibiotic-loaded polymeric NPs.",
      "startOffset" : 130,
      "endOffset" : 135
    }, {
      "referenceID" : 11,
      "context" : "7%.(12) The hospital-acquired infections manifest in a wide gamut of severe clinical ramifications, such as bacteremia, septic shock, ventilator-related pneumonia and massive soft tissue necrosis, and rapidly progress to systemic infections that eventually culminate in multiorgan failure and death.",
      "startOffset" : 3,
      "endOffset" : 7
    }, {
      "referenceID" : 12,
      "context" : "The hospital-acquired infections manifest in a wide gamut of severe clinical ramifications, such as bacteremia, septic shock, ventilator-related pneumonia and massive soft tissue necrosis, and rapidly progress to systemic infections that eventually culminate in multiorgan failure and death.(13) The control measures including implementation of hygiene, patient isolation and environmental decontamination have proved ineffective in keeping the infection at bay.",
      "startOffset" : 291,
      "endOffset" : 295
    }, {
      "referenceID" : 8,
      "context" : "Improper use of antibiotics has favored an upward trend in the development of resistance to almost all the available drugs, further compounding the clinical problem.(9,14) The challenge to control these infections is augmented in MDR bacteria such as those producing extended-spectrum β-lactamases and carbapenemases (K.",
      "startOffset" : 165,
      "endOffset" : 171
    }, {
      "referenceID" : 13,
      "context" : "Improper use of antibiotics has favored an upward trend in the development of resistance to almost all the available drugs, further compounding the clinical problem.(9,14) The challenge to control these infections is augmented in MDR bacteria such as those producing extended-spectrum β-lactamases and carbapenemases (K.",
      "startOffset" : 165,
      "endOffset" : 171
    }, {
      "referenceID" : 14,
      "context" : "Drug combination regimens have also proved ineffective due to formation of biofilms, agglomerates of bacterial colonies that adhere to a surface and resist traditional means of killing by avoiding contact with the antibiotics.(15) The bacteria survive in the biofilms for extended periods of time and are likely to be transmitted within the health care settings.",
      "startOffset" : 226,
      "endOffset" : 230
    }, {
      "referenceID" : 13,
      "context" : "The quandary of mechanisms of antibiotic resistance has retrogressed the clinical outcome and inflated the economic burden of infectious diseases, leaving the medical practitioners with few therapeutic options to address the emerging threat.(14) Furthermore, an arsenal of strategies has been employed by bacteria to subvert the host immune system, adversely impacting the surrogate markers of clinical course such as the length of hospitalization and hospital-related deaths.",
      "startOffset" : 241,
      "endOffset" : 245
    }, {
      "referenceID" : 2,
      "context" : "They utilize a multitude of virulence factors that conjointly render substantial impediment to phagocytes (macrophages and neutrophils) recruitment and activation.(3) The bacteria parasitize host cells by arresting or reprogramming phagosomal maturation, by escaping maturing phagosomes or by withstanding",
      "startOffset" : 163,
      "endOffset" : 166
    }, {
      "referenceID" : 15,
      "context" : "They secrete proteases that cleave NETs, degrade AMPs and express detoxifying enzymes like catalase to neutralize ROS and convert them into less harmful compounds.(16) Bacteria may also impair ROS production.",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 1,
      "context" : "Bacteria trigger phagocytic death through pore-forming cytolysins and escape host complement deposition and activation.(2) They release complementdegrading and complement-inactivating enzymes and inhibit membrane attack complex polymerization, thereby impeding bacteriolysis.",
      "startOffset" : 119,
      "endOffset" : 122
    }, {
      "referenceID" : 5,
      "context" : "Self-colonization of bacteria to form biofilms further leads to immune subterfuge.(6) Bacteria subvert In te rn at io na l J ou rn al o f N an om ed ic in e do w nl oa de d fr om h ttp s: //w w w .",
      "startOffset" : 82,
      "endOffset" : 85
    }, {
      "referenceID" : 16,
      "context" : "Bacteria may directly infect DC, dampening its interleukin (IL)-12 and tumor necrosis factor-alpha (TNF-α) production, thereby crippling the adaptive immune response.(17) Immune evasion favors bacterial persistence, resulting in increased antibiotic use and selection for MDR pathogens, thus emphasizing the need for alternate antimicrobial therapies.",
      "startOffset" : 166,
      "endOffset" : 170
    }, {
      "referenceID" : 15,
      "context" : "Immune evasion favors bacterial persistence, resulting in increased antibiotic use and selection for MDR pathogens, thus emphasizing the need for alternate antimicrobial therapies.(16)",
      "startOffset" : 180,
      "endOffset" : 184
    }, {
      "referenceID" : 13,
      "context" : "However, this perspective advocates ever-expanding threats accountable to indiscriminate use of antimicrobials resulting in escalated incidence of antibiotic resistance and epidemics of hypervirulent pathogens among vulnerable patients.(14) Bacteria have progressively eroded the effectiveness of not only a single antibiotic by developing resistance but concurrently multiple drugs that were previously effective.",
      "startOffset" : 236,
      "endOffset" : 240
    }, {
      "referenceID" : 14,
      "context" : "The biofilm-related infections are extremely defiant to antimicrobial arsenal and spread rampantly in the community.(15) The normal gut microbiota that otherwise maintains the immune functions is also targeted by antibiotic spectrum.",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 17,
      "context" : "by bacteria (Figure 1B) has been reported to occur through horizontal gene transfer on plasmids or transposons by transformation, conjugation and transduction or by spontaneously mutating the existing genes.(18) The resistance becomes rampant due to selective pressure for microbes expressing resistance genes against the antimicrobial drug, created by overuse of antibiotics, non-patient compliance or use of timedependent drugs with long half-lives or microbiostatic drugs.",
      "startOffset" : 207,
      "endOffset" : 211
    }, {
      "referenceID" : 6,
      "context" : "The resistance becomes rampant due to selective pressure for microbes expressing resistance genes against the antimicrobial drug, created by overuse of antibiotics, non-patient compliance or use of timedependent drugs with long half-lives or microbiostatic drugs.(7) Modes of resistance mechanisms(19) that endanger the efficacy of antibiotic arsenal are summed up as follows.",
      "startOffset" : 263,
      "endOffset" : 266
    }, {
      "referenceID" : 19,
      "context" : "Overexpression of transmembrane multidrug efflux pumps as well as reduced uptake results in sub-toxic levels of drugs within the microbial cells.(20) In P.",
      "startOffset" : 145,
      "endOffset" : 149
    }, {
      "referenceID" : 20,
      "context" : "aeruginosa, lowering the permeability of the cell wall to carbapenems.(21) In case of both Gram-positive and Gram-negative bacteria, one of the genes encoding tetracycline efflux pumps (TetA) is normally not expressed due to TetR repressor protein.",
      "startOffset" : 70,
      "endOffset" : 74
    }, {
      "referenceID" : 6,
      "context" : "However, tetracycline binds to and inactivates TetR, thereby inducing TetA expression that catalyzes drug efflux.(7)",
      "startOffset" : 113,
      "endOffset" : 116
    }, {
      "referenceID" : 6,
      "context" : "coli.(7) This mechanism also accounts for conferring resistance against aminoglycosides, macrolides, β-lactams, sulfonamides, linezolid, tetracyclines, rifampin and quinolones.",
      "startOffset" : 5,
      "endOffset" : 8
    }, {
      "referenceID" : 6,
      "context" : "This mechanism also accounts for conferring resistance against aminoglycosides, macrolides, β-lactams, sulfonamides, linezolid, tetracyclines, rifampin and quinolones.(7,22) Resistance genes coding for enzymes that methylate 23S rRNA of the 50S ribosomal subunit and 16S rRNA of the 30S ribosomal subunit inhibit binding by macrolides (such as erythromycin) and aminoglycosides, respectively.",
      "startOffset" : 167,
      "endOffset" : 173
    }, {
      "referenceID" : 21,
      "context" : "This mechanism also accounts for conferring resistance against aminoglycosides, macrolides, β-lactams, sulfonamides, linezolid, tetracyclines, rifampin and quinolones.(7,22) Resistance genes coding for enzymes that methylate 23S rRNA of the 50S ribosomal subunit and 16S rRNA of the 30S ribosomal subunit inhibit binding by macrolides (such as erythromycin) and aminoglycosides, respectively.",
      "startOffset" : 167,
      "endOffset" : 173
    }, {
      "referenceID" : 6,
      "context" : "Resistance genes coding for enzymes that methylate 23S rRNA of the 50S ribosomal subunit and 16S rRNA of the 30S ribosomal subunit inhibit binding by macrolides (such as erythromycin) and aminoglycosides, respectively.(7,23)",
      "startOffset" : 218,
      "endOffset" : 224
    }, {
      "referenceID" : 22,
      "context" : "Resistance genes coding for enzymes that methylate 23S rRNA of the 50S ribosomal subunit and 16S rRNA of the 30S ribosomal subunit inhibit binding by macrolides (such as erythromycin) and aminoglycosides, respectively.(7,23)",
      "startOffset" : 218,
      "endOffset" : 224
    }, {
      "referenceID" : 4,
      "context" : "β-Lactamases, having broad-spectrum activity against most of the β-lactam antibiotics, including cephalosporins, have evolved by gene transfer.(5,21) Chloramphenicol acetyltransferases modify chloramphenicol, making it unable to bind to 50S ribosomal subunit and inhibit protein synthesis.",
      "startOffset" : 143,
      "endOffset" : 149
    }, {
      "referenceID" : 20,
      "context" : "β-Lactamases, having broad-spectrum activity against most of the β-lactam antibiotics, including cephalosporins, have evolved by gene transfer.(5,21) Chloramphenicol acetyltransferases modify chloramphenicol, making it unable to bind to 50S ribosomal subunit and inhibit protein synthesis.",
      "startOffset" : 143,
      "endOffset" : 149
    }, {
      "referenceID" : 6,
      "context" : "Covalent modification also affords resistance against tobramycin, gentamycin, chloramphenicol, kanamycin, macrolides, tetracyclines, quinolones and streptogramins.(7,23)",
      "startOffset" : 163,
      "endOffset" : 169
    }, {
      "referenceID" : 22,
      "context" : "Covalent modification also affords resistance against tobramycin, gentamycin, chloramphenicol, kanamycin, macrolides, tetracyclines, quinolones and streptogramins.(7,23)",
      "startOffset" : 163,
      "endOffset" : 169
    }, {
      "referenceID" : 6,
      "context" : "aureus and Neisseria meningitidis acquire sulfonamide resistance by producing its inhibitor (para-aminobenzoic acid) that competes for binding the active site of bacterial dihydropteroate synthetase.(7,24) Mutations in this enzyme have also been found in many clinical isolates, downgrading sulfonamide-based therapies to second- or thirdline options.",
      "startOffset" : 199,
      "endOffset" : 205
    }, {
      "referenceID" : 23,
      "context" : "aureus and Neisseria meningitidis acquire sulfonamide resistance by producing its inhibitor (para-aminobenzoic acid) that competes for binding the active site of bacterial dihydropteroate synthetase.(7,24) Mutations in this enzyme have also been found in many clinical isolates, downgrading sulfonamide-based therapies to second- or thirdline options.",
      "startOffset" : 199,
      "endOffset" : 205
    }, {
      "referenceID" : 14,
      "context" : "aeruginosa.(15) Biofilms can also favor gene transfer between bacteria, thus spreading antibiotic resistance and transforming a previously non-virulent commensal into a virulent pathogen.",
      "startOffset" : 11,
      "endOffset" : 15
    }, {
      "referenceID" : 24,
      "context" : "Biofilms can also favor gene transfer between bacteria, thus spreading antibiotic resistance and transforming a previously non-virulent commensal into a virulent pathogen.(25)",
      "startOffset" : 171,
      "endOffset" : 175
    }, {
      "referenceID" : 26,
      "context" : "Zerovalent bismuth-containing NPs have shown promise in treating infections due to drug-resistant bacteria in combination with X-rays.(27) Among the metalcontaining NPs, Au NPs have moderate antibacterial activity unless their surface is modified.",
      "startOffset" : 134,
      "endOffset" : 138
    }, {
      "referenceID" : 30,
      "context" : "On the other hand, upsurge in resistance to Ag NPs has been reported due to genetic alterations in bacteria.(31) The deposition of silver In te rn at io na l J ou rn al o f N an om ed ic in e do w nl oa de d fr om h ttp s: //w w w .",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 31,
      "context" : "Al 2 O 3 NPs promote horizontal conjugative transfer of MDR genes, increasing antibiotic resistance.(32) The high toxicity of CuO NPs causes oxidative lesions, while DNA damage induced by ZnO and TiO 2 NPs limits the efficacy of these NPs.",
      "startOffset" : 100,
      "endOffset" : 104
    }, {
      "referenceID" : 32,
      "context" : "Nonetheless, NPs have emerged as alternative antimicrobial approach to combat biofilms and for treating severe bacterial infections.(33) The NPs-mediated elimination of the microbes may be microbicidal, or the effect may be microbiostatic, wherein the growth of bacteria is arrested and metabolic activities are ceased and the killing is potentiated by the host’s immune cells.",
      "startOffset" : 132,
      "endOffset" : 136
    }, {
      "referenceID" : 27,
      "context" : "The molecular mechanisms by which metalbased NPs annihilate MDR bacteria, resulting in disturbance in respiration and inhibition of cellular growth, have been extensively reviewed.(28,29,33) Table 1 summarizes the metallic NPs that have been reported for antibacterial activity via an array of mechanisms enlisted as follows.",
      "startOffset" : 180,
      "endOffset" : 190
    }, {
      "referenceID" : 28,
      "context" : "The molecular mechanisms by which metalbased NPs annihilate MDR bacteria, resulting in disturbance in respiration and inhibition of cellular growth, have been extensively reviewed.(28,29,33) Table 1 summarizes the metallic NPs that have been reported for antibacterial activity via an array of mechanisms enlisted as follows.",
      "startOffset" : 180,
      "endOffset" : 190
    }, {
      "referenceID" : 32,
      "context" : "The molecular mechanisms by which metalbased NPs annihilate MDR bacteria, resulting in disturbance in respiration and inhibition of cellular growth, have been extensively reviewed.(28,29,33) Table 1 summarizes the metallic NPs that have been reported for antibacterial activity via an array of mechanisms enlisted as follows.",
      "startOffset" : 180,
      "endOffset" : 190
    }, {
      "referenceID" : 27,
      "context" : "Ag and ZnO NPs have been reported to exert antibacterial activity by release of Ag+ and Zn++ that disrupt the membrane.(28,29,35,39) The antibacterial action of Ag NPs is revealed by interaction of Ag+ with sulfhydryl groups in enzymes and other cellular constituents, making them",
      "startOffset" : 119,
      "endOffset" : 132
    }, {
      "referenceID" : 28,
      "context" : "Ag and ZnO NPs have been reported to exert antibacterial activity by release of Ag+ and Zn++ that disrupt the membrane.(28,29,35,39) The antibacterial action of Ag NPs is revealed by interaction of Ag+ with sulfhydryl groups in enzymes and other cellular constituents, making them",
      "startOffset" : 119,
      "endOffset" : 132
    }, {
      "referenceID" : 34,
      "context" : "Ag and ZnO NPs have been reported to exert antibacterial activity by release of Ag+ and Zn++ that disrupt the membrane.(28,29,35,39) The antibacterial action of Ag NPs is revealed by interaction of Ag+ with sulfhydryl groups in enzymes and other cellular constituents, making them",
      "startOffset" : 119,
      "endOffset" : 132
    }, {
      "referenceID" : 38,
      "context" : "Ag and ZnO NPs have been reported to exert antibacterial activity by release of Ag+ and Zn++ that disrupt the membrane.(28,29,35,39) The antibacterial action of Ag NPs is revealed by interaction of Ag+ with sulfhydryl groups in enzymes and other cellular constituents, making them",
      "startOffset" : 119,
      "endOffset" : 132
    }, {
      "referenceID" : 39,
      "context" : "Cu++ interacts with amine and carboxyl groups on the surfaces of microbial cells, such as Bacillus subtilis.(40) Au NPs also result in bacterial membrane disruption.",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 36,
      "context" : "Inhibition of DNA replication and DNA degradation has also been reported with Cu NPs.(37,40) Bi NPs in combination with X-ray treatment emit electrons, with formation of free radicals that damage bacterial DNA.",
      "startOffset" : 85,
      "endOffset" : 92
    }, {
      "referenceID" : 39,
      "context" : "Inhibition of DNA replication and DNA degradation has also been reported with Cu NPs.(37,40) Bi NPs in combination with X-ray treatment emit electrons, with formation of free radicals that damage bacterial DNA.",
      "startOffset" : 85,
      "endOffset" : 92
    }, {
      "referenceID" : 47,
      "context" : "Bi NPs in combination with X-ray treatment emit electrons, with formation of free radicals that damage bacterial DNA.(48)",
      "startOffset" : 117,
      "endOffset" : 121
    }, {
      "referenceID" : 35,
      "context" : "Adsorption of nanomaterials to bacterial cell The electrostatic interaction between the NPs and the microbial cells affects its toxicity, with the positively charged NPs being more toxic as has been observed with TiO 2 and surfacemodified Au NPs.(36,41) The NPs adsorption to the surface of Table 1 Metallic nanomaterials-based probable bactericidal effects",
      "startOffset" : 246,
      "endOffset" : 253
    }, {
      "referenceID" : 40,
      "context" : "Adsorption of nanomaterials to bacterial cell The electrostatic interaction between the NPs and the microbial cells affects its toxicity, with the positively charged NPs being more toxic as has been observed with TiO 2 and surfacemodified Au NPs.(36,41) The NPs adsorption to the surface of Table 1 Metallic nanomaterials-based probable bactericidal effects",
      "startOffset" : 246,
      "endOffset" : 253
    } ],
    "year" : 2017,
    "abstractText" : "and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). International Journal of Nanomedicine 2017:12 8211–8225 International Journal of Nanomedicine Dovepress",
    "creator" : "Adobe InDesign CS3 (5.0)"
  }
}